Amedeo Smart

Free Medical Literature Service


 

Amedeo

Head and Neck Cancer

  Free Subscription

Articles published in
Thyroid
    December 2024
  1. HAMIDI S, Yedururi S, Hu MI, Busaidy NL, et al
    Efficacy and Safety of Selective RET Inhibitors in Patients with Advanced Hereditary Medullary Thyroid Carcinoma.
    Thyroid. 2024 Dec 4. doi: 10.1089/thy.2024.0495.
    >> Share

    October 2024
  2. NGUYEN TNA, Nguyen VPT, Kurohama H, Akazawa Y, et al
    Association Between Gross Features and Coexistence of BRAF(V600E) and TERT Promoter Mutations in Papillary Thyroid Carcinomas: A Combined Analysis Incorporating Clinicopathologic Features.
    Thyroid. 2024 Oct 31. doi: 10.1089/thy.2024.0310.
    >> Share

  3. KUHLEN M, Wellbrock M, Kunstreich M, Trubenbach C, et al
    Incidence and Temporal Patterns of Differentiated Thyroid Carcinoma in Children and Adolescents in Germany: A Pooled Analysis Based on Data from the German Malignant Endocrine Tumor Registry and the German Childhood Cancer Registry.
    Thyroid. 2024 Oct 30. doi: 10.1089/thy.2024.0534.
    >> Share

  4. PILZ MJ, Seyringer S, Singer S, Ioannidis G, et al
    The Cancer-Specific Health Economic Measure QLU-C10D is Valid and Responsive for Assessing Health Utility in Patients with Thyroid Cancer.
    Thyroid. 2024 Oct 30. doi: 10.1089/thy.2024.0396.
    >> Share

  5. ELDEIRY LS, Lawrence JE, Taneja C, Margulies D, et al
    American Thyroid Association Policy Statement: Impact of Changes in Fine Needle Aspiration Biopsy Reimbursement on Clinical Care of Patients with Thyroid Nodules in the United States.
    Thyroid. 2024 Oct 16. doi: 10.1089/thy.2024.0442.
    >> Share

  6. ASHTON J, Morrison S, Erkanli A, Wildman-Tobriner B, et al
    Assessment of the Diagnostic Performance of a Commercially Available Artificial Intelligence Algorithm for Risk Stratification of Thyroid Nodules on Ultrasound.
    Thyroid. 2024 Oct 15. doi: 10.1089/thy.2024.0410.
    >> Share

    September 2024
  7. KROPINSKA A, Ledwon A, Paliczka Cieslik E, Olczyk T, et al
    Changing Clinical Presentation of Pediatric Differentiated Thyroid Cancer in Poland: A Retrospective Cohort Study Spanning 45 Years.
    Thyroid. 2024 Sep 25. doi: 10.1089/thy.2024.0109.
    >> Share

  8. KIM MJ, Won H, Kim WB, Lee EK, et al
    Comparison of Patient Reported Outcomes between Active surveillance and Immediate Lobectomy in Patients with Low-risk Papillary Thyroid Microcarcinoma: Initial Findings from the KoMPASS cohort.
    Thyroid. 2024 Sep 17. doi: 10.1089/thy.2024.0264.
    >> Share

  9. MASTNIKOVA K, Bulanova Pekova B, Kuklikova V, Vaclavikova E, et al
    DICER1 Variants in Pediatric and Young Adult Thyroid Nodules.
    Thyroid. 2024 Sep 16. doi: 10.1089/thy.2024.0188.
    >> Share

  10. VAN DE BERG DJ, Rodriguez Schaap PM, Jamaludin FS, van Santen HM, et al
    The Definition of Recurrence of Differentiated Thyroid Cancer: A Systematic Review of the Literature.
    Thyroid. 2024 Sep 16. doi: 10.1089/thy.2024.0271.
    >> Share

  11. SONG Z, Wu C, Kasmirski J, Gillis A, et al
    Incidental Thyroid Nodules on Computed Tomography: A Systematic Review and Meta-analysis Examining Prevalence, Follow-up and Risk of Malignancy.
    Thyroid. 2024 Sep 16. doi: 10.1089/thy.2024.0313.
    >> Share

  12. LEE JY, Lee MK, Lee JH, Kim K, et al
    Cancer risks of patients with Graves' disease who received antithyroid drugs as initial treatment: A nationwide population-based analysis.
    Thyroid. 2024 Sep 3. doi: 10.1089/thy.2024.0178.
    >> Share

    August 2024
  13. LEE JY, Na DG, Sim JS, Sung JY, et al
    A Prospective Clinical Trial of Radiofrequency Ablation in Patients with Low-Risk Unifocal Papillary Thyroid Microcarcinoma favoring Active Surveillance over Surgery.
    Thyroid. 2024 Aug 30. doi: 10.1089/thy.2024.0098.
    >> Share

  14. WANG Z, Yao Q, Bao L, Chang H, et al
    Clinicopathological Features of CCDC6-RET and NCOA4-RET Fusions in Thyroid Cancer: A Single-center Retrospective Cohort Study in a Chinese Population.
    Thyroid. 2024 Aug 30. doi: 10.1089/thy.2024.0151.
    >> Share

  15. PRINZI A, van Velsen EFS, Belfiore A, Frasca F, et al
    Brain Metastasis in Differentiated Thyroid Cancer: Clinical Presentation, Diagnosis and Management.
    Thyroid. 2024 Aug 20. doi: 10.1089/thy.2024.0240.
    >> Share

  16. WEN S, Wu Y, Wang JY, Ni Z, et al
    BRAFV600E/ p-ERK/ p-DRP1(Ser616) Promotes Tumor Progression and Reprogramming of Glucose Metabolism in Papillary Thyroid Cancer.
    Thyroid. 2024 Aug 20. doi: 10.1089/thy.2023.0700.
    >> Share

  17. RICARTE-FILHO JC, Reichenberger ER, Hinkle K, Isaza A, et al
    TG-IGF1R: A Novel Receptor Tyrosine Kinase Fusion Oncogene in Pediatric Thyroid Cancer.
    Thyroid. 2024 Aug 6. doi: 10.1089/thy.2024.0224.
    >> Share

    July 2024
  18. KHENG M, Manzella A, Chao JC, Laird AM, et al
    Reoperation Rates after Initial Thyroid Lobectomy for Patients with Thyroid Cancer: A National Cohort Study.
    Thyroid. 2024 Jul 25. doi: 10.1089/thy.2024.0128.
    >> Share

  19. GOLDFARB M
    In the Heat of the Moment: Thermal Ablation for 'All Things Thyroid'.
    Thyroid. 2024 Jul 23. doi: 10.1089/thy.2024.0391.
    >> Share

  20. PARK SI, Baek JH, Lee DH, Chung SR, et al
    Radiofrequency Ablation for the Treatment of Benign Thyroid nodules: 10-Year Experience.
    Thyroid. 2024 Jul 23. doi: 10.1089/thy.2024.0082.
    >> Share

  21. SCAPPATICCIO L, Ferrazzano P, Di Martino N, Negro R, et al
    Prevalence and Management of Complications of Percutaneous Ethanol Injection for Cystic Thyroid Nodules: A Systematic Review of Literature and Meta-analysis.
    Thyroid. 2024 Jul 20. doi: 10.1089/thy.2024.0241.
    >> Share

  22. ANTUNEZ AG, Saucke MC, Bushaw KJ, Chiu AS, et al
    Surgeon preference for maximizing medical care is associated with recommending more extensive surgery for low-risk thyroid cancer.
    Thyroid. 2024 Jul 20. doi: 10.1089/thy.2024.0170.
    >> Share

  23. SABBAGH MF, Janovitz T, Dias-Santagata D, Siegmund SE, et al
    FGFR Alterations in Thyroid Carcinoma: A Novel Class of Primary Drivers with Significant Therapeutic Implications and Secondary Molecular Events Potentially Mediating Resistance in Thyroid Malignancy.
    Thyroid. 2024 Jul 14. doi: 10.1089/thy.2024.0216.
    >> Share

  24. SZABO YAMASHITA T, Williams-Perez S, Ehsan S, Mulder MB, et al
    The Multi-institutional Medullary Thyroid Cancer Collaborative Registry (MTCCoRe): Can a rare tumor registry accurately represent the real-world patient population?
    Thyroid. 2024 Jul 10. doi: 10.1089/thy.2024.0239.
    >> Share

  25. MATRONE A, Kroiss M, Gild ML, Hamidi S, et al
    Erectile dysfunction in patients treated with selpercatinib for RET altered thyroid cancer.
    Thyroid. 2024 Jul 10. doi: 10.1089/thy.2024.0129.
    >> Share

    June 2024
  26. PERAMPALAM S, Wu K, Gild ML, Tacon L, et al
    Association between lymphocytic thyroiditis and papillary thyroid cancer harboring mutant BRAF: a systematic review and meta-analysis.
    Thyroid. 2024 Jun 28. doi: 10.1089/thy.2024.0142.
    >> Share

  27. DEVON K, Tinckam K, Humar A, Madani A, et al
    Successful Deceased Donor Parathyroid Allotransplantation: A Novel Approach in a Patient with Severe Refractory Hypoparathyroidism after Thyroidectomy for Thyroid Cancer.
    Thyroid. 2024 Jun 26. doi: 10.1089/thy.2024.0115.
    >> Share

  28. DIONISIO T, Mauri G
    Ultrasound Evaluation of Ablated Thyroid Nodules: An Emerging Problem.
    Thyroid. 2024 Jun 25. doi: 10.1089/thy.2024.0244.
    >> Share

  29. KOTWAL A, Vance K, Hajric K, Yuil-Valdes A, et al
    Characterization of immune infiltrate along the leading edge of differentiated thyroid cancer.
    Thyroid. 2024 Jun 25. doi: 10.1089/thy.2024.0072.
    >> Share

  30. GINZBERG SP, Sharpe J, Passman JE, Amjad W, et al
    Revisiting the Relationship between Tumor Size and Risk in Well-Differentiated Thyroid Cancer.
    Thyroid. 2024 Jun 15. doi: 10.1089/thy.2023.0327.
    >> Share

  31. LEE Y, Alam MR, Park H, Yim K, et al
    Improved diagnostic accuracy of thyroid fine-needle aspiration cytology with artificial intelligence technology.
    Thyroid. 2024 Jun 14. doi: 10.1089/thy.2023.0384.
    >> Share

    May 2024
  32. SCHNEIDER AB, Mihailescu DV
    Radiation Exposure and Benign Thyroid Nodules.
    Thyroid. 2024 May 27. doi: 10.1089/thy.2024.0279.
    >> Share

  33. KIM CA, Baek S, Yoo J, Chung SR, et al
    Tumor Growth Kinetics Based on Initial Tumor Volume Doubling Time in Active Surveillance of Low-Risk Papillary Thyroid Carcinoma.
    Thyroid. 2024 May 17. doi: 10.1089/thy.2024.0054.
    >> Share

  34. CHEN D, Carr G, Worden FP, Veenstra CM, et al
    Survival Prognostication in Patients with Differentiated Thyroid Cancer and Distant Metastases: A SEER Population-Based Study.
    Thyroid. 2024 May 17. doi: 10.1089/thy.2023.0709.
    >> Share

  35. PITOIA F, Abelleira E, Roman-Gonzalez A, Danilovic DLS, et al
    Neoadjuvant Treatment of Locally Advanced Thyroid Cancer: A Preliminary Latin American Experience.
    Thyroid. 2024 May 17. doi: 10.1089/thy.2024.0090.
    >> Share

  36. CAHOON EK, Grimm E, Mabuchi K, Mai JZ, et al
    Prevalence of thyroid nodules in residents of Ukraine exposed as children or adolescents to iodine-131 from the Chornobyl accident.
    Thyroid. 2024 May 17. doi: 10.1089/thy.2023.0654.
    >> Share

  37. BIONDI B
    TSH Suppression in Differentiated Thyroid Cancer Patients. Still More Questions than Answers after 30 Years.
    Thyroid. 2024 May 14. doi: 10.1089/thy.2024.0232.
    >> Share

  38. GUBBI S, Al-Jundi M, Foerster P, Cardenas S, et al
    The Effect of Thyrotropin Suppression on Survival Outcomes in Patients with Differentiated Thyroid Cancer: A Systematic Review and Meta-analysis.
    Thyroid. 2024 May 8. doi: 10.1089/thy.2023.0711.
    >> Share

  39. MACHENS A, Lorenz K, Weber F, Dralle H, et al
    Anatomic Patterns of Nodal Spread in Unilateral Papillary and Medullary Thyroid Cancer.
    Thyroid. 2024 May 8. doi: 10.1089/thy.2024.0076.
    >> Share

    April 2024
  40. CHOI YS, Jeon MJ, Doolittle WKL, Song DE, et al
    Macrophage-induced carboxypeptidase A4 promotes the progression of anaplastic thyroid cancer.
    Thyroid. 2024 Apr 26. doi: 10.1089/thy.2023.0427.
    >> Share

  41. ZHOU Y, Yang F, Zhou H, Lv S, et al
    Alginate/carboxymethyl chitosan core-shell microspheres co-loaded with docetaxel/doxorubicin reverse chemotherapy resistance in anaplastic thyroid carcinoma.
    Thyroid. 2024 Apr 25. doi: 10.1089/thy.2024.0023.
    >> Share

  42. HIDALGO-ALVAREZ J, Bianco AC
    A Scholarly Dialog on Recent Trends in NIH Funding for the Thyroid Field.
    Thyroid. 2024 Apr 25. doi: 10.1089/thy.2024.0084.
    >> Share

  43. TAHARA M, Takami H, Ito Y, Okamoto T, et al
    A Prospective Cohort Study Exploring the Effect of Lenvatinib Planned Drug Holidays in Treatment of Differentiated Thyroid Cancer.
    Thyroid. 2024 Apr 17. doi: 10.1089/thy.2023.0553.
    >> Share

    March 2024
  44. WINTER J, Axelsson E, Bjorkhem-Bergman L, Ihre Lundgren C, et al
    Five-year follow-up of health-related quality of life in differentiated thyroid cancer patients treated with total thyroidectomy and radioiodine in Sweden: a nationwide prospective cohort study.
    Thyroid. 2024 Mar 25. doi: 10.1089/thy.2023.0691.
    >> Share

  45. SAWKA AM, Ghai S, Rotstein L, Irish JC, et al
    Decision Regret Following the Choice of Surgery or Active Surveillance for Small, Low-Risk Papillary Thyroid Cancer: A Prospective Cohort Study.
    Thyroid. 2024 Mar 13. doi: 10.1089/thy.2023.0634.
    >> Share

  46. STILLMAN M, Kuo EJ, Liou R, Almuqate A, et al
    Molecular Testing for Bethesda III Thyroid nodules: Trends in Implementation, Cytopathology Call Rates, Surgery Rates, and Malignancy Yield at a Single Institution.
    Thyroid. 2024 Mar 12. doi: 10.1089/thy.2023.0664.
    >> Share

    February 2024
  47. JIANG YJ, Xia Y, Hu Y, Han Z, et al
    Identification of P21 (CDKN1A) Activated Kinase 4 as a susceptibility gene for Familial Non-medullary Thyroid Carcinoma.
    Thyroid. 2024 Feb 27. doi: 10.1089/thy.2023.0564.
    >> Share

  48. SFREDDO HJ, Koh ES, Zhao K, Swartzwelder CE, et al
    RAS-Mutated Cytologically Indeterminate Thyroid Nodules: Prevalence of Malignancy and Behavior Under Active Surveillance.
    Thyroid. 2024 Feb 26. doi: 10.1089/thy.2023.0544.
    >> Share

  49. FERNANDEZ-VELASCO P, Perez Lopez P, Torres B, Delgado E, et al
    Clinical evaluation of an Artificial Intelligence-based decision support system for the diagnosis and ACR TI-RADS classification of thyroid nodules.
    Thyroid. 2024 Feb 18. doi: 10.1089/thy.2023.0603.
    >> Share

  50. HAMPTON J, Alam A, Zdenkowski N, Rowe C, et al
    Fear of Cancer Recurrence in Differentiated Thyroid Cancer Survivors - A Systematic Review.
    Thyroid. 2024 Feb 18. doi: 10.1089/thy.2023.0642.
    >> Share

  51. PASCHKE R
    Why did the rapid increase of reflex molecular testing of indeterminate FNA cytologies in the USA not impact thyroidectomy rates? What is the lesson to be learned?
    Thyroid. 2024 Feb 12. doi: 10.1089/thy.2024.0042.
    >> Share

  52. ESPINOSA DE YCAZA AE, Brito JP, McCoy R, Shao H, et al
    GLP-1 receptor agonists and thyroid cancer: a narrative review.
    Thyroid. 2024 Feb 12. doi: 10.1089/thy.2023.0530.
    >> Share

  53. TAHARA M, Kiyota N, Imai H, Takahashi S, et al
    A phase II study of encorafenib in combination with binimetinib in patients with metastatic BRAF-mutated thyroid cancer in Japan.
    Thyroid. 2024 Feb 12. doi: 10.1089/thy.2023.0547.
    >> Share

    January 2024
  54. BROCK P, Liyanarachchi S, Nieminen TT, Chan C, et al
    CHEK2 founder variants and thyroid cancer risk.
    Thyroid. 2024 Jan 27. doi: 10.1089/thy.2023.0529.
    >> Share

  55. LIU CH, Zhao H, Lu Y, Xia Y, et al
    A long-term study comparing the quality of life and psychological status of patients with highly suspicious thyroid nodules
    Thyroid. 2024 Jan 25. doi: 10.1089/thy.2023.0478.
    >> Share

  56. HUANG Y, Chan SJ, Wright JD, Kuo JH, et al
    Does the Adoption of Molecular Testing Cause Decreased Thyroidectomy Rates in a National Cohort? A Quasi-Experimental Study of High- Vs. Low-Adoption States.
    Thyroid. 2024 Jan 22. doi: 10.1089/thy.2023.0651.
    >> Share

  57. YANG F, Yang M, Liu Y, Zhou C, et al
    PDLIM7 promotes tumor metastasis in papillary thyroid carcinoma via stabilizing FAK protein.
    Thyroid. 2024 Jan 20. doi: 10.1089/thy.2023.0497.
    >> Share

  58. HAMIDI S, Iyer P, Dadu R, Gule-Monroe M, et al
    Checkpoint Inhibition in Addition to Dabrafenib/Trametinib for BRAF(V600E) Mutated Anaplastic Thyroid Carcinoma.
    Thyroid. 2024 Jan 16. doi: 10.1089/thy.2023.0573.
    >> Share

  59. MIYAUCHI A
    Response to Xiang J. and Zhang H. re: "Active Surveillance Outcomes of Patients with Low-Risk Papillary Thyroid Microcarcinoma According to Levothyroxine Treatment Status".
    Thyroid. 2024 Jan 16. doi: 10.1089/thy.2023.0697.
    >> Share

  60. XIANG J, Zhang H
    Letter to the Editor: Active Surveillance Outcomes of Patients with Low-Risk Papillary Thyroid Microcarcinoma According to Levothyroxine Treatment Status.
    Thyroid. 2024 Jan 16. doi: 10.1089/thy.2023.0605.
    >> Share


  61. Correction to: Factors Associated with Survival in Anaplastic Thyroid Carcinoma: A Multicenter Study from the ENDOCAN-TUTHYREF Network by Jannin et al. Thyroid 2023;33(10):1190-1200; doi: 10.1089/thy.2023.0164.

    Thyroid. 2024;34:140.
    >> Share

    December 2023
  62. TRAN TV, Schonfeld SJ, Pasqual E, Haymart MR, et al
    All-cause and cause-specific mortality among low-risk differentiated thyroid cancer survivors in the United States.
    Thyroid. 2023 Dec 27. doi: 10.1089/thy.2023.0449.
    >> Share

  63. PARK SK, Ryoo JH, Kim MH, Jung JY, et al
    Association between eight autoimmune diseases and thyroid cancer: A Nationwide Cohort Study.
    Thyroid. 2023 Dec 27. doi: 10.1089/thy.2023.0353.
    >> Share

  64. BERNARDI S, Rosolen V, Barbone F, Borgato S, et al
    Clinical outcomes of thermal ablation retreatment of benign thyroid nodules: A multicenter study from the Italian minimally-invasive treatments of the thyroid group.
    Thyroid. 2023 Dec 27. doi: 10.1089/thy.2023.0501.
    >> Share

  65. SHIRAI YT, Hoshi N, Ward JM, Liu H, et al
    Establishment and characterization of amitrole-induced mouse thyroid adenomatous nodule-derived cell lines.
    Thyroid. 2023 Dec 27. doi: 10.1089/thy.2023.0341.
    >> Share

  66. POMA AM, Macerola E, Ghossein R MD, Tallini G, et al
    Prevalence of differentiated high-grade thyroid carcinoma among well-differentiated tumors: a systematic review and meta-analysis.
    Thyroid. 2023 Dec 19. doi: 10.1089/thy.2023.0350.
    >> Share

  67. TAYLOR SR, Chiu AS, Hoxha I, Saucke MC, et al
    Assessing Fear of Thyroid Cancer in the General U.S. Population: A Cross-Sectional Study.
    Thyroid. 2023 Dec 19. doi: 10.1089/thy.2023.0479.
    >> Share

  68. CHENG SY, Kimura T, Doolittle WKL, Kruhlak M, et al
    Inhibition of MEK signaling attenuates cancer stem cell activity in anaplastic thyroid cancer.
    Thyroid. 2023 Dec 19. doi: 10.1089/thy.2023.0521.
    >> Share

  69. HUSTON-PATERSON HH, Mao YV, Tseng CH, Kim J, et al
    Rural-urban Disparities in the Continuum of Thyroid Cancer Care: Analysis of 92,794 cases.
    Thyroid. 2023 Dec 19. doi: 10.1089/thy.2023.0357.
    >> Share

  70. FEI-ZHANG D, Verma R, Arimoto R, Lawrence AS, et al
    Social Vulnerability Association with Thyroid Cancer Disparities in the United States.
    Thyroid. 2023 Dec 9. doi: 10.1089/thy.2023.0370.
    >> Share

  71. HURST ZA, Liyanarachchi S, Brock P, He H, et al
    Presumed Pathogenic Germline and Somatic Variants in African American Thyroid Cancer.
    Thyroid. 2023 Dec 7. doi: 10.1089/thy.2023.0487.
    >> Share

  72. CAPDEVILA J, Krajewska J, Hernando J, Robinson B, et al
    Increased progression-free survival with cabozantinib versus placebo in patients with radioiodine-refractory differentiated thyroid cancer irrespective of prior VEGFR-targeted therapy and tumor histology: a subgroup analysis of the COSMIC-311 study.
    Thyroid. 2023 Dec 7. doi: 10.1089/thy.2023.0463.
    >> Share

  73. BROCK P, Sevigny M, Liyanarachchi S, Comiskey DF Jr, et al
    PDPR gene variants predisposing to papillary thyroid cancer.
    Thyroid. 2023 Dec 7. doi: 10.1089/thy.2023.0560.
    >> Share

  74. CENSI S, Galuppini F, Clausi C, Battheu F, et al
    Tumor grade and molecular characteristics associated with survival in sporadic medullary thyroid carcinoma.
    Thyroid. 2023 Dec 4. doi: 10.1089/thy.2023.0482.
    >> Share

  75. CAVALLO AC, Pitoia F, Roberti J, Brenzoni P, et al
    Optimizing Diagnostic Accuracy of Fine Needle Aspiration Biopsy Calcitonin Measurements in Detecting Medullary Thyroid Carcinoma.
    Thyroid. 2023 Dec 4. doi: 10.1089/thy.2023.0313.
    >> Share

    November 2023
  76. PARK SJ, Kim M, Jeong S, Park YJ, et al
    Association Between Antibiotic Exposure and Thyroid Cancer: A Nationwide Cohort Study in South Korea.
    Thyroid. 2023 Nov 27. doi: 10.1089/thy.2023.0235.
    >> Share

  77. DE KOSTER EJ, Morreau H, Bleumink GS, van Engen-van Grunsven I, et al
    Molecular diagnostics and [18F]FDG-PET/CT in indeterminate thyroid nodules: complementing techniques or waste of valuable resources?
    Thyroid. 2023 Nov 27. doi: 10.1089/thy.2023.0337.
    >> Share

  78. SUBBIAH V, Hu MI, Mansfield AS, Taylor MH, et al
    Pralsetinib in Patients with Advanced/metastatic RET-altered Thyroid Cancer: Updated Efficacy and Safety Data from the ARROW Study.
    Thyroid. 2023 Nov 27. doi: 10.1089/thy.2023.0363.
    >> Share

  79. CAMPBELL DJ, Estephan LE, Sina E, Mastrolonardo EV, et al
    Evaluating ChatGPT responses on thyroid nodules for patient education.
    Thyroid. 2023 Nov 27. doi: 10.1089/thy.2023.0491.
    >> Share

  80. ASSAAD S, Dov D, Park C, Davis R, et al
    A preliminary study comparing the performance of thyroid molecular tests to a deep learning algorithm in predicting malignancy in indeterminate thyroid fine needle aspiration biopsies.
    Thyroid. 2023 Nov 27. doi: 10.1089/thy.2023.0054.
    >> Share

  81. KENNEDY E, Zhang C, Qadadha Y, Cheng CF, et al
    Rates of Detecting Thyroid Nodules Recommended for Biopsy with Ultrasound: Are All Indications Equal?
    Thyroid. 2023 Nov 19. doi: 10.1089/thy.2023.0234.
    >> Share

  82. TARASOVA VD, Tsai J, Masannat J, Hernandez-Prera J, et al
    Characterization of the thyroid cancer genomic landscape by plasma-based circulating tumor DNA next-generation sequencing.
    Thyroid. 2023 Nov 14. doi: 10.1089/thy.2023.0204.
    >> Share

  83. LI X, Peng C, Liu Y, Hu Y, et al
    Modified ACR TI-RADS and Modified AI TI-RADS for Thyroid Nodules: A Multicenter Retrospective Study.
    Thyroid. 2023 Nov 11. doi: 10.1089/thy.2023.0429.
    >> Share

  84. LEE I, Grice JV, Ji X, Chen Q, et al
    A Pilot Nonrandomized Controlled Trial Examining the Use of Artificial Tears on the Radioactivity of Tears after Radioactive Iodine Treatment for Thyroid Cancer.
    Thyroid. 2023 Nov 2. doi: 10.1089/thy.2023.0338.
    >> Share

  85. TORO-TOBON D, Morris JC 3rd, Hilger CR, Peskey C, et al
    Clinical outcomes of radioactive iodine redifferentiation therapy in previously iodine refractory differentiated thyroid cancers.
    Thyroid. 2023 Nov 2. doi: 10.1089/thy.2023.0456.
    >> Share

  86. MOOG S, Lamartina L, Bani MA, Al Ghuzlan A, et al
    Alkylating Agent-Induced High Tumor Mutational Burden in Medullary Thyroid Cancer and Response to Immune Checkpoint Inhibitors: Two Case Reports.
    Thyroid. 2023;33:1368-1373.
    >> Share

    October 2023
  87. LI X, Li Y, Yan L, Xiao J, et al
    Sonographic Evolution and Pathologic Findings of Papillary Thyroid Cancer after Radiofrequency Ablation: a 5-Year Retrospective Cohort Study.
    Thyroid. 2023 Oct 26. doi: 10.1089/thy.2023.0415.
    >> Share

  88. BACH K, Ansari P, Ansari H, Mott NM, et al
    Health-related Quality of Life in Patients with Low-risk Differentiated Thyroid Cancer: A Systematic Review Examining the Extent of Thyroidectomy.
    Thyroid. 2023 Oct 20. doi: 10.1089/thy.2023.0328.
    >> Share

  89. XU B, Viswanathan K, Ahadi MS, Ahmadi S, et al
    Association of the Genomic Profile of Medullary Thyroid Carcinoma with Tumor Characteristics and Clinical Outcomes in an International Multicenter Study.
    Thyroid. 2023 Oct 16. doi: 10.1089/thy.2023.0279.
    >> Share

  90. JANNIN A, Giudici F, de la Fouchardiere C, Al Ghuzlan A, et al
    Factors Associated with Survival in Anaplastic Thyroid Carcinoma: A Multicenter Study from the ENDOCAN-TUTHYREF Network.
    Thyroid. 2023;33:1190-1200.
    >> Share

    September 2023
  91. PAPADOPOULOU A, Asvold BO, Burgess S, Kus A, et al
    Height, autoimmune thyroid disease and thyroid cancer: a Mendelian randomisation study.
    Thyroid. 2023 Sep 29. doi: 10.1089/thy.2023.0272.
    >> Share

  92. STEWARDSON P, Eszlinger M, Wu J, Khalil M, et al
    Prospective Validation of ThyroSPEC Molecular Testing of Indeterminate Thyroid Nodule Cytology Following Diagnostic Pathway Optimization.
    Thyroid. 2023 Sep 24. doi: 10.1089/thy.2023.0255.
    >> Share

  93. XIAO X, Chen M, Sang Y, Xue J, et al
    Methylation-mediated silencing of ATF3 promotes thyroid cancer progression by regulating prognostic genes in the MAPK and PI3K/AKT pathways.
    Thyroid. 2023 Sep 24. doi: 10.1089/thy.2023.0157.
    >> Share

  94. GUPTA M, Misariu AM, Saydy N, Nichols A, et al
    A Multicentre Retrospective Study of Anaplastic Thyroid Cancer in the Era of Targeted Therapy in a Public Health Care System: Canada's Experience.
    Thyroid. 2023 Sep 19. doi: 10.1089/thy.2023.0088.
    >> Share

  95. DE LEO S, D'Elia S, Grani G, Dondi F, et al
    A Prospective, Multicenter Study Examining the Relationship between Thyroid Cancer Treatment Outcomes and the Presence of Autoimmune Thyroiditis.
    Thyroid. 2023 Sep 19. doi: 10.1089/thy.2023.0052.
    >> Share

  96. BALAKIROUCHENANE D, Seban R, Groussin L, Puszkiel A, et al
    Pharmacokinetics/Pharmacodynamics of dabrafenib and trametinib for redifferentiation and treatment of radioactive-iodine-resistant mutated advanced differentiated thyroid cancer.
    Thyroid. 2023 Sep 19. doi: 10.1089/thy.2023.0228.
    >> Share

  97. BIONDI B MD, Pucci M, Pontieri G, Formisano P, et al
    PRELIMINARY RESULTS OF A DOUBLE-BLIND RANDOMIZED CONTROLLED TRIAL EVALUATING THE CARDIO-METABOLIC EFFECTS OF LEVOTHYROXINE AND LIOTHYRONINE COMPARED TO LEVOTHYROXINE WITH PLACEBO IN ATHYREOTIC LOW RISK THYROID CANCER PATIENTS.
    Thyroid. 2023 Sep 19. doi: 10.1089/thy.2023.0135.
    >> Share

  98. GUNDA V, Ghosh C, Hu J, Zhang L, et al
    Combination BRAFV600E inhibition with the multitargeting tyrosine kinase inhibitor axitinib shows additive anticancer activity in BRAFV600E-mutant anaplastic thyroid cancer.
    Thyroid. 2023 Sep 7. doi: 10.1089/thy.2023.0201.
    >> Share

  99. FAGIN JA, Nikiforov YE
    Progress in Thyroid Cancer Genomics: A 40-Year Journey.
    Thyroid. 2023 Sep 4. doi: 10.1089/thy.2023.0045.
    >> Share

    August 2023
  100. SINCLAIR CF, Baek JH, Hands KE, Hodak SP, et al
    General principles for the safe performance, training and adoption of ablation techniques for benign thyroid nodules: An American Thyroid Association Statement.
    Thyroid. 2023 Aug 29. doi: 10.1089/thy.2023.0281.
    >> Share

  101. PAK SJ, Kwon D, Kim BC, Cho JW, et al
    Contralateral Low-to-Intermediate Suspicion Nodule is Not a Contraindication for Lobectomy in Patients with Papillary Thyroid Carcinoma.
    Thyroid. 2023 Aug 25. doi: 10.1089/thy.2023.0270.
    >> Share

  102. ROSS DS
    Response to Yan et al. re "Could Radioactive Iodine be a Preferred Therapy for Graves' Hyperthyroidism Patients with Large Goiters? A Viewpoint from China.
    Thyroid. 2023 Aug 25. doi: 10.1089/thy.2023.0423.
    >> Share

  103. TUTTLE RM MD
    Is there a role for levothyroxine therapy in euthyroid patients on active surveillance for papillary microcarcinomas?
    Thyroid. 2023 Aug 19. doi: 10.1089/thy.2023.0424.
    >> Share

  104. SALAS-LUCIA F, Liao XH, Jiang H, Dumitrescu AM, et al
    The Relationship between Fetal THRB Genotype and Maternal Thyroid Function.
    Thyroid. 2023 Aug 19. doi: 10.1089/thy.2023.0236.
    >> Share

  105. BANG JI, Park S, Kim K, Seo Y, et al
    The Diagnostic Value of F-18 FDG PET/CT in Differentiated Thyroid Cancer Patients with Elevated Thyroglobulin/Thyroglobulin Antibody Levels and Negative Iodine Scintigraphy: A Systematic Review and Meta-analysis.
    Thyroid. 2023 Aug 19. doi: 10.1089/thy.2023.0264.
    >> Share

  106. YAN S, Li X, Yan B
    Letter to the Editor: Could Radioactive Iodine Be a Preferred Therapy for Graves' Hyperthyroidism Patients with Large Goiters? A Viewpoint from China.
    Thyroid. 2023 Aug 18. doi: 10.1089/thy.2023.0332.
    >> Share

  107. WADSLEY J, Ainsworth G, Coulson AB, Garcez K, et al
    Results of the SEL-I-METRY phase II trial on resensitisation of advanced iodine refractory differentiated thyroid cancer to radioiodine therapy.
    Thyroid. 2023 Aug 11. doi: 10.1089/thy.2022.0707.
    >> Share

  108. LEVINE RA
    History of Thyroid Ultrasound.
    Thyroid. 2023;33:894-902.
    >> Share

    July 2023
  109. SAHAKIAN N, Romanet P, Mirebeau-Prunier D, Paladino C, et al
    Letter to the Editor: The Somatic RET M918T Variant May Modify the Natural History of Germline RET L790F MEN2-Related Medullary Thyroid Carcinoma.
    Thyroid. 2023 Jul 19. doi: 10.1089/thy.2023.0110.
    >> Share

  110. DE LEO S, Trevisan M, Re Sarto GV, Moneta C, et al
    TUMOR LYSIS SYNDROME DURING SELPERCATINIB TREATMENT IN A PATIENT WITH MEDULLARY THYROID CANCER.
    Thyroid. 2023 Jul 18. doi: 10.1089/thy.2023.0214.
    >> Share

  111. SINGER S, Al-Ibraheem A, Pinto M, Iakovou I, et al
    International phase IV field study for the reliability and validity of the European Organisation for Research and Treatment of Cancer Thyroid Cancer Module EORTC QLQ-THY34.
    Thyroid. 2023 Jul 14. doi: 10.1089/thy.2023.0221.
    >> Share

  112. ALI SZ, Baloch ZW, Cochand-Priollet B, Schmitt FC, et al
    The 2023 Bethesda System for Reporting Thyroid Cytopathology.
    Thyroid. 2023 Jul 8. doi: 10.1089/thy.2023.0141.
    >> Share

    June 2023
  113. MARCZYK VR, Recamonde-Mendoza M, Maia AL, Goemann IM, et al
    Classification of Thyroid Tumors Based on DNA Methylation Patterns.
    Thyroid. 2023 Jun 30. doi: 10.1089/thy.2023.0074.
    >> Share

  114. LEBOULLEUX S, Benisvy D, Taieb D, Attard M, et al
    MERAIODE: A Phase II Redifferentiation Trial with Trametinib and 131I in Metastatic Radioactive Iodine Refractory RAS Mutated Differentiated thyroid Cancer.
    Thyroid. 2023 Jun 23. doi: 10.1089/thy.2023.0240.
    >> Share

  115. O'NEILL C, Carlson M, Rowe C, Fradgley E, et al
    Hearing the voices of Australian thyroid cancer survivors: qualitative thematic analysis of semi-structured interviews identifies unmet support needs.
    Thyroid. 2023 Jun 19. doi: 10.1089/thy.2023.0080.
    >> Share

  116. YAMAMOTO M, Miyauchi A, Ito Y, Fujishima M, et al
    Active Surveillance Outcomes of Patients with Low-risk Papillary Thyroid Microcarcinoma According to Levothyroxine Treatment Status.
    Thyroid. 2023 Jun 13. doi: 10.1089/thy.2023.0046.
    >> Share

  117. BAUDIN C, Bressand A, Buffet C, Menegaux F, et al
    Dysfunction of the salivary and lacrimal glands after radioiodine therapy for thyroid cancer: Results of the START study after 6-months of follow-up.
    Thyroid. 2023 Jun 10. doi: 10.1089/thy.2023.0090.
    >> Share

  118. TORO-TOBON D, Loor-Torres R, Duran M, Fan JW, et al
    Artificial Intelligence in Thyroidology: A Narrative Review of the Current Applications, Associated Challenges, and Future Directions.
    Thyroid. 2023 Jun 6. doi: 10.1089/thy.2023.0132.
    >> Share

  119. PAPINI E, Hegedus L
    Minimally Invasive Ablative Treatments for Benign Thyroid Nodules: Current Evidence and Future Directions.
    Thyroid. 2023 Jun 2. doi: 10.1089/thy.2023.0263.
    >> Share

  120. DANIELS GH, Ross DS
    Radioactive Iodine: A Living History.
    Thyroid. 2023;33:666-673.
    >> Share

    May 2023
  121. BOGSRUD TV, Jacobsen M, Durski JM, Engelsen O, et al
    Repeat Redifferentiation of Radioiodine Refractory BRAFV600E Mutated Thyroid Cancer With Dabrafenib.
    Thyroid. 2023 May 22. doi: 10.1089/thy.2022.0651.
    >> Share

  122. IESATO A, Li S, Sadow PM, Abbasian M, et al
    The tyrosine kinase inhibitor lenvatinib inhibits anaplastic thyroid carcinoma growth by targeting pericytes in the tumor microenvironment.
    Thyroid. 2023 May 12. doi: 10.1089/thy.2022.0597.
    >> Share

  123. BALLAL S, Yadav MP, Roesch F, Raju S, et al
    Head-to-head comparison of [68Ga]Ga-DOTA.SA.FAPi and [68Ga]Ga-DOTANOC PET/CT imaging for the follow-up surveillance of patients with medullary thyroid cancer.
    Thyroid. 2023 May 12. doi: 10.1089/thy.2023.0008.
    >> Share

  124. MIYAUCHI A, Ito Y, Fujishima M, Miya A, et al
    Long-term outcomes of active surveillance and immediate surgery for adult patients with low-risk papillary thyroid microcarcinoma: 30-year experience.
    Thyroid. 2023 May 11. doi: 10.1089/thy.2023.0076.
    >> Share

  125. CHORTI A, Bontinis V, Tzikos G, Bontinis A, et al
    Minimally invasive treatments of benign thyroid nodules: a network meta-analysis of short-term outcomes.
    Thyroid. 2023 May 11. doi: 10.1089/thy.2022.0671.
    >> Share

  126. GHOSSEIN R, Ganly I, Tuttle RM, Xu B, et al
    Large (>4 cm) Intrathyroidal Encapsulated Well-Differentiated Follicular Cell-Derived Carcinoma Without Vascular Invasion May Have Negligible Risk of Recurrence Even When Treated with Lobectomy Alone.
    Thyroid. 2023;33:586-592.
    >> Share

    April 2023
  127. SHAN Z, Li Y, Li Y, Wang H, et al
    Changing iodine status and the incidence of thyroid disease in mainland China: A prospective 20-year follow-up study.
    Thyroid. 2023 Apr 21. doi: 10.1089/thy.2022.0505.
    >> Share

  128. LOPEZ B, Fligor SC, Randolph GW, James BC, et al
    Inequities in Thyroid Cancer Care: Populations Most at Risk for Delays in Diagnosis and Treatment.
    Thyroid. 2023 Apr 13. doi: 10.1089/thy.2022.0723.
    >> Share

  129. KHANAL T, Rajan N, Li W, Liyanarachchi S, et al
    The RCAN1.4 metastasis suppressor is hypermethylated at intron 1 in thyroid cancer.
    Thyroid. 2023 Apr 13. doi: 10.1089/thy.2022.0687.
    >> Share

  130. COLLINS R, Chaves N, Lee GJ, Broekhuis J, et al
    Urban and Rural Surgical Practice Patterns for Papillary Thyroid Carcinoma.
    Thyroid. 2023 Apr 4. doi: 10.1089/thy.2022.0711.
    >> Share

  131. LEBBINK CA, van Santen HM, Daneman A, Wasserman JD, et al
    Does ultrasound really contribute to detection of residual/recurrent disease after pediatric thyroidectomy? Preliminary data supporting a "thyroglobulin-first" approach.
    Thyroid. 2023 Apr 4. doi: 10.1089/thy.2022.0576.
    >> Share

  132. BRANDLER TC, Zhou F, Liu CZ, Serrano A, et al
    Molecular Profiles of Non-Invasive, Minimally Invasive and Invasive Follicular Patterned Thyroid Neoplasms with Papillary Nuclear Features.
    Thyroid. 2023 Apr 4. doi: 10.1089/thy.2023.0047.
    >> Share

    March 2023
  133. LIU JB, Baugh KA, Ramonell K, McCoy KL, et al
    Molecular Testing Predicts Incomplete Response to Initial Therapy in Differentiated Thyroid Carcinoma without Lateral Neck or Distant Metastasis at Presentation: Retrospective Cohort Study.
    Thyroid. 2023 Mar 27. doi: 10.1089/thy.2023.0060.
    >> Share

  134. ALSHARIF O, Panella T, Nodit L, Hu MI, et al
    ETV6-NTRK2 Fusion Identified in a Patient with Medullary Thyroid Carcinoma.
    Thyroid. 2023 Mar 24. doi: 10.1089/thy.2022.0630.
    >> Share

  135. BIKAS A, Wong K, Pappa T, Ahmadi S, et al
    Papillary Thyroid Carcinomas with Tall Cell Features: An Intermediate Entity between Classic and Tall Cell Subtypes.
    Thyroid. 2023 Mar 24. doi: 10.1089/thy.2022.0534.
    >> Share

  136. ALZUMAILI B, Krumeich LN, Collins R, Kravchenko T, et al
    A Comprehensive Study on the Diagnosis and Management of Non-Invasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP).
    Thyroid. 2023 Mar 24. doi: 10.1089/thy.2023.0035.
    >> Share

  137. GILD ML, Bullock M, Tsang V, Clifton-Bligh R, et al
    Challenges and strategies to combat resistance mechanisms in thyroid cancer therapeutics.
    Thyroid. 2023 Mar 16. doi: 10.1089/thy.2022.0704.
    >> Share

    February 2023
  138. SHAHA AR
    Anaplastic Thyroid Cancer: Shifting Paradigms-A Ray of Hope.
    Thyroid. 2023 Feb 28. doi: 10.1089/thy.2023.29150.
    >> Share

  139. KWON D, Kulich M, Mack WJ, Martinez Monedero R, et al
    Malignancy Risk of Thyroid Nodules That Are Not Classifiable by the ATA Ultrasound Risk Stratification System: A Systematic Review and Meta-Analysis.
    Thyroid. 2023 Feb 28. doi: 10.1089/thy.2022.0672.
    >> Share

  140. CORRIVEAU-PARENTEAU E, Turkdogan S, Noik M, Forest VI, et al
    Clinical Experience of Cytologically Indeterminate Thyroid Nodules Designated as Negative on Molecular Testing Using Thyroseq V3: A Retrospective Cohort Study.
    Thyroid. 2023 Feb 24. doi: 10.1089/thy.2022.0555.
    >> Share

  141. CHOU R, Dana T, Mayson SE, Cibas ES, et al
    Ultrasound Follow-up of Benign Thyroid Nodules: A Scoping Review.
    Thyroid. 2023 Feb 18. doi: 10.1089/thy.2022.0692.
    >> Share

  142. OLEINIKOV K, Yaakov E, Mizrachi A, Hirsch D, et al
    A Comparison of Outcomes in Medullary Thyroid Carcinoma Patients with and without a Preoperative Diagnosis: A Multicenter Retrospective Cohort Study.
    Thyroid. 2023 Feb 15. doi: 10.1089/thy.2022.0424.
    >> Share

  143. CHEN C, Cao J, Wang Y, Han X, et al
    Health-related quality of life and thyroid cancer-specific symptoms in patients treated for differentiated thyroid cancer: a single center, cross-sectional survey from Mainland China.
    Thyroid. 2023 Feb 15. doi: 10.1089/thy.2022.0490.
    >> Share

  144. SUGISAWA C, Narumi S, Tanase-Nakao K, Ayako H, et al
    Adult Thyroid Outcomes of Congenital Hypothyroidism.
    Thyroid. 2023 Feb 15. doi: 10.1089/thy.2022.0481.
    >> Share

  145. VAN NOSTRAND D, Vetysman I, Kulkarni K, Heimlich SL, et al
    Redifferentiation of Differentiated Thyroid Cancer: Clinical Insights from a Narrative Review of Literature.
    Thyroid. 2023 Feb 15. doi: 10.1089/thy.2022.0632.
    >> Share

  146. WANG Z, Guan H
    Hear the Patient's Voice Regarding Implementation of Thyroid Cancer Active Surveillance in China.
    Thyroid. 2023 Feb 15. doi: 10.1089/thy.2023.0058.
    >> Share

  147. HIRSCH D, Yackobovitch-Gavan M, Lazar L
    Infertility and Pregnancy Rates in Female Thyroid Cancer Survivors: A Retrospective Cohort Study Using Healthcare Administrative Data from Israel.
    Thyroid. 2023 Feb 14. doi: 10.1089/thy.2022.0501.
    >> Share

  148. ZHAO X, Wang JR, Dadu R, Busaidy N, et al
    Surgery after BRAF-directed therapy is associated with improved survival in BRAF V600E mutant Anaplastic Thyroid Cancer.
    Thyroid. 2023 Feb 10. doi: 10.1089/thy.2022.0504.
    >> Share

  149. WADSLEY J
    Redifferentiation therapy for iodine refractory differentiated thyroid cancers- current status.
    Thyroid. 2023 Feb 6. doi: 10.1089/thy.2023.0057.
    >> Share

    January 2023
  150. ZHU P, Zhang Q, Wu Q, Shi G, et al
    Barriers and Facilitators to the Choice of Active Surveillance for Low-risk Papillary Thyroid Cancer in China: A Qualitative Study Examining Patient Perspectives.
    Thyroid. 2023 Jan 31. doi: 10.1089/thy.2022.0347.
    >> Share

  151. BARBI WALTER L, Scheffel RS, Zanella AB, Farenzena M, et al
    Active Surveillance of Differentiated Thyroid Cancer Metastatic Cervical Lymph Nodes: A Retrospective Single-Center Cohort Study.
    Thyroid. 2023 Jan 21. doi: 10.1089/thy.2022.0542.
    >> Share

  152. WIJEWARDENE A, Bastard K, Wang B, Gild M, et al
    A Case Report of Poor Response to Selpercatinib in the Presence of a 632_633 RET Deletion.
    Thyroid. 2023;33:119-125.
    >> Share

    December 2022
  153. NIKITSKI AV, Condello V, Divakaran SS, Nikiforov YE, et al
    Inhibition of ALK-Signaling Overcomes STRN-ALK-Induced Downregulation of the Sodium Iodine Symporter and Restores Radioiodine Uptake in Thyroid Cells.
    Thyroid. 2022 Dec 31. doi: 10.1089/thy.2022.0533.
    >> Share

  154. CHEN YH, Cabanillas M, Sperling J, Xu L, et al
    Prior thyroid and non-thyroid cancer history do not significantly alter overall survival in patients diagnosed with anaplastic thyroid carcinoma.
    Thyroid. 2022 Dec 13. doi: 10.1089/thy.2022.0350.
    >> Share

  155. CONTRERA KJ, Gule-Monroe M, Hu MI, Cabanillas M, et al
    Neoadjuvant Selective RET Inhibitor for Medullary Thyroid Cancer: A Case Series.
    Thyroid. 2022 Dec 11. doi: 10.1089/thy.2022.0506.
    >> Share

    November 2022
  156. TESSLER FN, Thomas J
    Artificial Intelligence for Evaluation of Thyroid Nodules: A Primer.
    Thyroid. 2022 Nov 24. doi: 10.1089/thy.2022.0560.
    >> Share

  157. WILHELM A, Conroy PC, Calthorpe L, Shui AM, et al
    Disease-Specific Survival Trends for Patients Presenting with Differentiated Thyroid Cancer and Distant Metastases in the United States, 1992-2018.
    Thyroid. 2022 Nov 18. doi: 10.1089/thy.2022.0353.
    >> Share

  158. THIESMEYER JW, Egan C, Greenberg JA, Beninato T, et al
    Prepubertal Children with Papillary Thyroid Carcinoma Present with More Invasive Disease than Adolescents and Young Adults.
    Thyroid. 2022 Nov 10. doi: 10.1089/thy.2022.0098.
    >> Share

  159. KITAHARA CM
    Obesity, physical activity, and thyroid cancer risk - disentangling true associations from detection bias.
    Thyroid. 2022 Nov 9. doi: 10.1089/thy.2022.0618.
    >> Share

  160. SHOBAB L, Wartofsky L
    Perspective: The Molecular Landscape of Radioactive Iodine Refractory Differentiated Thyroid Cancer and Poorly Differentiated Thyroid Cancer.
    Thyroid. 2022 Nov 7. doi: 10.1089/thy.2022.0428.
    >> Share

  161. DE LEO S, Trevisan M, Colombo C, Moneta C, et al
    HYPOCALCEMIA DURING LENVATINIB TREATMENT FOR ADVANCED THYROID CANCER: CLINICAL FEATURES AND MANAGEMENT IN A REAL-LIFE SETTING.
    Thyroid. 2022 Nov 3. doi: 10.1089/thy.2022.0439.
    >> Share

  162. DAVIS S, Ullmann TM, Roman S
    Disparities in Treatment for Differentiated Thyroid Cancer.
    Thyroid. 2022 Nov 3. doi: 10.1089/thy.2022.0432.
    >> Share

  163. DONG W, Okamoto T, Ji X, Xiang J, et al
    Conditional Survival Rate Estimates for Anaplastic Thyroid Cancer Beyond the First Year: An Analysis of SEER Data (2004 to 2019).
    Thyroid. 2022 Nov 3. doi: 10.1089/thy.2022.0339.
    >> Share

  164. LINKS MH, Lefrandt JD, Lisman T, van der Boom T, et al
    Fluctuations in thyroid hormone levels during initial treatment for differentiated thyroid carcinoma are associated with changes in hemostasis: a prospective cohort study.
    Thyroid. 2022 Nov 2. doi: 10.1089/thy.2022.0299.
    >> Share

  165. TANEJA C, Yip L, Morariu EM, Seethala R, et al
    Clinicopathologic Characteristics and Postsurgical Follow-Up of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features in the Postnomenclature Revision Era.
    Thyroid. 2022;32:1346-1352.
    >> Share

    October 2022
  166. WILDMAN-TOBRINER B, Hoang JK
    Incidental Thyroid Nodules on CT: A Radiologist's Perspective.
    Thyroid. 2022 Oct 19. doi: 10.1089/thy.2022.0553.
    >> Share

  167. GARCIA-LOZANO CA, Sanabria A
    Preliminary report of active surveillance as a conservative strategy for Bethesda IV thyroid nodules.
    Thyroid. 2022 Oct 17. doi: 10.1089/thy.2022.0296.
    >> Share

  168. WU J, Hu XY, Ghaznavi S, Kinnear S, et al
    The Prospective Implementation of the 2015 ATA Guidelines and Modified ATA Recurrence Risk Stratification System for Treatment of Differentiated Thyroid Cancer in a Canadian Tertiary Care Referral Setting.
    Thyroid. 2022 Oct 13. doi: 10.1089/thy.2022.0055.
    >> Share

  169. DUVAL MADS, Ferreira CV, Marmitt L, Dora JM, et al
    An undetectable postoperative calcitonin level is associated with long-term disease-free survival in medullary thyroid carcinoma: Results of a retrospective cohort study.
    Thyroid. 2022 Oct 12. doi: 10.1089/thy.2022.0295.
    >> Share

  170. SASAKI T, Miyauchi A, Fujishima M, Ito Y, et al
    Comparison of postoperative unfavorable events in patients with low-risk papillary thyroid carcinoma: Immediate surgery vs. conversion surgery following active surveillance.
    Thyroid. 2022 Oct 7. doi: 10.1089/thy.2022.0444.
    >> Share

  171. HO AS, Bastien AJ, Sacks W
    Thyroid Cancer Active Surveillance: The Devil You Know Or The Devil You Don't.
    Thyroid. 2022 Oct 7. doi: 10.1089/thy.2022.0541.
    >> Share

  172. LEE EK, Moon JH, Hwangbo Y, Ryu CH, et al
    Progression of Low-risk Papillary Thyroid Microcarcinoma During Active Surveillance: Interim analysis of a Multicenter Prospective Cohort Study of Active Surveillance on Papillary Thyroid Microcarcinoma (MAeSTro) in Korea.
    Thyroid. 2022 Oct 7. doi: 10.1089/thy.2021.0614.
    >> Share

  173. GOLDFARB M, Franco A
    SURVIVORSHIP, QUALITY OF LIFE, AND TRANSITION TO ADULT CARE FOR PEDIATRIC AND ADOLESCENT THYROID CANCER SURVIVORS.
    Thyroid. 2022 Oct 3. doi: 10.1089/thy.2022.0407.
    >> Share

    September 2022
  174. TUTTLE RM MD, Fagin JA, Minkowitz G, Wong RJ, et al
    Active surveillance of papillary thyroid cancer-frequency and time course of the 6 most common tumor volume kinetic patterns.
    Thyroid. 2022 Sep 30. doi: 10.1089/thy.2022.0325.
    >> Share

  175. GUILMETTE J, Dias-Santagata D, Lennerz JK, Selig MK, et al
    Primary Thyroid Neoplasm with Fetal Morphology Associated with DICER1 Mutations: Expanding the Diagnostic Profile of Thyroblastoma.
    Thyroid. 2022 Sep 30. doi: 10.1089/thy.2022.0060.
    >> Share

  176. SORENSEN SM, Urbute A, Frederiksen K, Kjaer SK, et al
    Pre-pregnancy Body Mass Index and risk of differentiated thyroid cancer: a prospective cohort study of more than 440,000 Danish women.
    Thyroid. 2022 Sep 29. doi: 10.1089/thy.2022.0259.
    >> Share

  177. HE Q, Cao H, Zhao Y, Chen P, et al
    DPP4 stabilizes integrin alpha4beta1 complex to promote thyroid cancer cell metastasis by activating TGF-beta signaling pathway.
    Thyroid. 2022 Sep 27. doi: 10.1089/thy.2022.0317.
    >> Share

  178. LEE H, Krishnan V, Wirth LJ, Nucera C, et al
    Case Report of CCDC149-ALK fusion: a novel genetic alteration and a clinically relevant target in metastatic papillary thyroid carcinoma.
    Thyroid. 2022 Sep 23. doi: 10.1089/thy.2022.0389.
    >> Share

  179. DRAKE T, Gravely A, Ensrud K, Billington CJ, et al
    Reporting of Incidental Thyroid Nodules on Chest CT and the Impact on Nodule Evaluation: A Retrospective Cohort Study.
    Thyroid. 2022 Sep 21. doi: 10.1089/thy.2022.0349.
    >> Share

  180. HALADA S, Baran J, Bauer AJ, Ricarte-Filho JC, et al
    Clinicopathologic Characteristics of Pediatric Follicular Variant of Papillary Thyroid Carcinoma Subtypes: A Retrospective Cohort Study.
    Thyroid. 2022 Sep 14. doi: 10.1089/thy.2022.0239.
    >> Share

  181. GRANI G, Lamartina L, Montesano T, Giacomelli L, et al
    Prevalence of thyroid nodules and thyroid cancer in individuals with a first-degree family history of non-medullary thyroid cancer: a cross-sectional study based on sonographic screening.
    Thyroid. 2022 Sep 13. doi: 10.1089/thy.2022.0253.
    >> Share

  182. QIANG J, Alwithenani R, Uleryk E, Ezzat S, et al
    Risk of Adverse Cardiovascular Outcomes in Differentiated Thyroid Cancer Survivors: A Systematic Review and Meta-analysis.
    Thyroid. 2022 Sep 8. doi: 10.1089/thy.2022.0209.
    >> Share

  183. BUI QA, Gunathilake M, Lee J, Lee EK, et al
    Relationship between physical activity levels and thyroid cancer risk: A prospective cohort study in Korea.
    Thyroid. 2022 Sep 7. doi: 10.1089/thy.2022.0250.
    >> Share

  184. SUZUKI S, Suzuki S, Iwadate M, Matsuzuka T, et al
    Possible association between thyroid nodule formation and developmental alterations in the pituitary-thyroid hormone axis in children and adolescents: The Fukushima Health Management Survey.
    Thyroid. 2022 Sep 6. doi: 10.1089/thy.2022.0327.
    >> Share

  185. EGAN C, Stefanova D, Thiesmeyer JW, Lee YJ, et al
    Proposed Risk Stratification and Patterns of Radioactive Iodine Therapy in Malignant Struma Ovarii.
    Thyroid. 2022;32:1101-1108.
    >> Share

    August 2022
  186. DIGENNARO C, Vahdat V, Jalali M, Toumi A, et al
    Assessing Bias and Limitations of Clinical Validation Studies of Molecular Diagnostic Tests for Indeterminate Thyroid Nodules: Systematic Review and Meta-Analysis.
    Thyroid. 2022 Aug 23. doi: 10.1089/thy.2022.0269.
    >> Share

  187. BAL C, Satapathy S, Tupalli A, Ballal S, et al
    Propensity Score Matched Outcome Analysis of Lobar Ablation versus Completion Thyroidectomy in Low-risk Differentiated Thyroid Cancer Patients: Median Follow-up of 11 Years.
    Thyroid. 2022 Aug 18. doi: 10.1089/thy.2022.0234.
    >> Share

  188. NIGAM A, Xu B, Spanheimer P, Ganly I, et al
    Tumor Grade Predicts for Calcitonin Doubling Times and Disease-Specific Outcomes After Resection of Medullary Thyroid Carcinoma.
    Thyroid. 2022 Aug 11. doi: 10.1089/thy.2022.0217.
    >> Share

  189. KIM S, Song SH, Lee CW, Kwon JT, et al
    Low-level environmental mercury exposure and thyroid cancer risk among residents living near national industrial complexes in South Korea: A population-based cohort study.
    Thyroid. 2022 Aug 11. doi: 10.1089/thy.2022.0084.
    >> Share

  190. BROSE M, Smit J, Lin CC, Tori M, et al
    Multi-kinase Inhibitors for the Treatment of Asymptomatic Radioactive Iodine-Refractory Differentiated Thyroid Cancer: Global, Non-Interventional Study (RIFTOS MKI).
    Thyroid. 2022 Aug 11. doi: 10.1089/thy.2022.0061.
    >> Share

  191. KEEFE G, Culbreath K, Cherella CE, Smith JR, et al
    Autoimmune Thyroiditis and Risk of Malignancy in Children with Thyroid Nodules.
    Thyroid. 2022 Aug 11. doi: 10.1089/thy.2022.0241.
    >> Share

  192. KUCHARECZKO A, Kopczynski J, Kowalik A, Hincza-Nowak K, et al
    A significance of concomitant BRAFV600E and TERT mutations in Polish patients with papillary thyroid microcarcinoma - a retrospective cohort study based on 430 cases.
    Thyroid. 2022 Aug 11. doi: 10.1089/thy.2022.0155.
    >> Share

  193. LI C, Gao Y, Zhou P, Yue T, et al
    Comparison of the robotic bilateral axillo-breast approach and conventional open thyroidectomy in pediatric patients: a retrospective cohort study.
    Thyroid. 2022 Aug 9. doi: 10.1089/thy.2022.0242.
    >> Share

  194. FINKELSTEIN S, Sistrunk J, Malchoff C, Thompson DV, et al
    A Retrospective Evaluation of the Diagnostic Performance of an Interdependent Pairwise microRNA Expression Analysis with a Mutation Panel in Indeterminate Thyroid Nodules.
    Thyroid. 2022 Aug 9. doi: 10.1089/thy.2022.0124.
    >> Share

    July 2022
  195. JERKOVICH F, Abelleira E, Bueno F, Guerrero L, et al
    Active surveillance of small metastatic lymph nodes as an alternative to surgery in selected patients with low risk papillary thyroid cancer: A retrospective cohort study.
    Thyroid. 2022 Jul 25. doi: 10.1089/thy.2022.0302.
    >> Share

  196. SKAUGEN JM, Taneja C, Liu JB, Wald AI, et al
    Performance of a Multigene Genomic Classifier in Thyroid Nodules with Suspicious for Malignancy Cytology.
    Thyroid. 2022 Jul 21. doi: 10.1089/thy.2022.0282.
    >> Share

  197. METE O, Asa SL
    Oncologic Outcome Prediction in Differentiated Thyroid Carcinoma: Assumption or Improved Accuracy?
    Thyroid. 2022 Jul 15. doi: 10.1089/thy.2022.0379.
    >> Share

  198. DOOLITTLE WKL, Zhao L, Cheng SY
    Blocking CDK7-mediated NOTCH1-cMYC Signaling Attenuates Cancer Stem Cell Activity in Anaplastic Thyroid Cancer.
    Thyroid. 2022 Jul 13. doi: 10.1089/thy.2022.0087.
    >> Share

  199. CORSELLO A, Ramunno V, Locantore P, Pacini G, et al
    Medullary Thyroid Cancer with Ectopic Cushing's Syndrome: A Case Report and Systematic Review of Detailed Cases from the Literature.
    Thyroid. 2022 Jul 12. doi: 10.1089/thy.2021.0696.
    >> Share

  200. RANDOLPH GW, Sosa JA, Hao Y, Angell TE, et al
    Preoperative Identification of Medullary Thyroid Carcinoma (MTC): Clinical Validation of the Afirma MTC RNA-Sequencing Classifier.
    Thyroid. 2022 Jul 6. doi: 10.1089/thy.2022.0189.
    >> Share

    June 2022
  201. PLITT G, Brewer T, Yehia L, Jin J, et al
    Development and progression of thyroid disease in PTEN hamartoma tumor syndrome: refined surveillance recommendations.
    Thyroid. 2022 Jun 27. doi: 10.1089/thy.2022.0181.
    >> Share

  202. NOTO B, Asmus I, Schafers M, Goerlich D, et al
    Predictors of anxiety and depression in differentiated thyroid cancer survivors: Results of a cross-sectional Study.
    Thyroid. 2022 Jun 23. doi: 10.1089/thy.2022.0067.
    >> Share

  203. PAPACHRISTOS AJ, Do K, Tsang V, Sywak M, et al
    Outcomes of papillary thyroid microcarcinoma presenting with palpable lateral lymphadenopathy.
    Thyroid. 2022 Jun 15. doi: 10.1089/thy.2022.0109.
    >> Share

  204. HWANGBO Y, Choi JY, Lee EK, Ryu CH, et al
    A cross-sectional survey of patient treatment choice in a multicenter prospective cohort study on active surveillance of papillary thyroid microcarcinoma (MAeSTro).
    Thyroid. 2022 Jun 13. doi: 10.1089/thy.2021.0619.
    >> Share

  205. BUSAIDY N, Konda B, Wei L, Wirth LJ, et al
    Dabrafenib vs dabrafenib + trametinib in BRAF-mutated radioactive iodine refractory differentiated thyroid cancer - results of a randomized, phase 2, open-label, multicenter trial.
    Thyroid. 2022 Jun 4. doi: 10.1089/thy.2022.0115.
    >> Share

    May 2022
  206. WIJEWARDENE A, Gill AJ, Gild M, Learoyd DL, et al
    A retrospective cohort study with prospective validation of predictors of differentiated thyroid cancer outcomes.
    Thyroid. 2022 May 27. doi: 10.1089/thy.2021.0563.
    >> Share

  207. HU TX, Nguyen DT, Patel MK, Beckett K, et al
    The Effect Modification of Ultrasound Risk Classification on Molecular Testing in Predicting the Risk of Malignancy in Cytologically Indeterminate Thyroid Nodules.
    Thyroid. 2022 May 25. doi: 10.1089/thy.2021.0659.
    >> Share

  208. ERICKSON T, Shih YP, Fass J, Jang M, et al
    T cells engineered to express immunoreceptors targeting the frequently expressed medullary thyroid cancer antigens calcitonin, CEA and RET M918T.
    Thyroid. 2022 May 19. doi: 10.1089/thy.2022.0020.
    >> Share

  209. HATASHIMA A, Archambeau B, Armbruster H, Xu M, et al
    An Evaluation of Clinical Efficacy of Immune Checkpoint Inhibitors for Patients with Anaplastic Thyroid Carcinoma.
    Thyroid. 2022 May 18. doi: 10.1089/thy.2022.0073.
    >> Share

  210. KIM K, Choi JY, Kim SJ, Lee EK, et al
    Active Surveillance Versus Immediate Surgery for Low-Risk Papillary Thyroid Microcarcinoma Patients in South Korea: A Cost-Minimization Analysis from the MAeSTro Study.
    Thyroid. 2022 May 16. doi: 10.1089/thy.2021.0679.
    >> Share

  211. YI W, Kim BH, Kim M, Kim J, et al
    Heart failure and stroke risks in users of liothyronine with or without levothyroxine compared to levothyroxine alone: A propensity score matched analysis.
    Thyroid. 2022 May 16. doi: 10.1089/thy.2021.0634.
    >> Share

  212. SORENSEN JR, Dossing H, Watt T, Cramon PK, et al
    The effect of laser thermal ablation on quality of life: Improvements in patients with solid-cystic thyroid nodules.
    Thyroid. 2022 May 16. doi: 10.1089/thy.2021.0665.
    >> Share

  213. LEE NY, Riaz N, Wu V, Brinkman T, et al
    A Pilot Study of Durvalumab (MEDI4736) with Tremelimumab in Combination with Image Guided Stereotactic Body Radiotherapy (SBRT) in the Treatment of Metastatic Anaplastic Thyroid Cancer.
    Thyroid. 2022 May 6. doi: 10.1089/thy.2022.0050.
    >> Share

    April 2022
  214. TOFT DJ, Schneider AB
    PROTECTING THE THYROID IN TIMES OF CONFLICT (UKRAINE 2022).
    Thyroid. 2022 Apr 25. doi: 10.1089/thy.2022.0135.
    >> Share

  215. SORENSEN SM, De la Cour CD, Maltesen T, Urbute A, et al
    Temporal trends in papillary and follicular thyroid cancer incidence from 1995 to 2019 in adults in Denmark according to education and income.
    Thyroid. 2022 Apr 22. doi: 10.1089/thy.2021.0602.
    >> Share

  216. KIM M, Jin M, Jeon MJ, Kim EY, et al
    Lenvatinib compared with sorafenib as a first-line treatment for radioactive iodinerefractory, progressive, differentiated thyroid carcinoma: Real-world outcomes in a multicenter retrospective cohort study.
    Thyroid. 2022 Apr 20. doi: 10.1089/thy.2022.0054.
    >> Share

  217. WEI J, Thwin M, Nickel B, Glover AR, et al
    Factors which inform individual decision making between active surveillance, hemithyroidectomy and total thyroidectomy for low-risk thyroid cancer: A scoping review.
    Thyroid. 2022 Apr 19. doi: 10.1089/thy.2021.0646.
    >> Share

  218. CHOU R, Dana T, Brent GA, Goldner W, et al
    Serum Thyroglobulin Measurement Following Surgery without Radioactive Iodine for Differentiated Thyroid Cancer: A Systematic Review.
    Thyroid. 2022 Apr 12. doi: 10.1089/thy.2021.0666.
    >> Share

  219. CAPDEVILA J, Klochikhin A, Leboulleux S, Isaev P, et al
    A Randomized, Double-Blind Noninferiority Study to Evaluate the Efficacy of the Cabozantinib Tablet at 60 mg per Day Compared with the Cabozantinib Capsule at 140 mg per Day in Patients With Progressive, Metastatic Medullary Thyroid Cancer.
    Thyroid. 2022 Apr 10. doi: 10.1089/thy.2022.0027.
    >> Share

    March 2022
  220. WANG Z, Tang C, Wang Y, Yin Z, et al
    Inclusion of the Number of Metastatic Lymph Nodes in the Staging System for Medullary Thyroid Cancer: Validating a Modified AJCC TNM Staging System.
    Thyroid. 2022 Mar 30. doi: 10.1089/thy.2021.0571.
    >> Share

  221. ZHANG F, Teng D, Tong N, Wang G, et al
    Gender-Specific Associations Between Metabolic Disorders and Thyroid Nodules: A Cross-Sectional Population-Based Study From China.
    Thyroid. 2022 Mar 23. doi: 10.1089/thy.2021.0686.
    >> Share

  222. MA LX, Espin-Garcia O, Bedard PL, Stockley TL, et al
    Clinical Application of Next-Generation Sequencing in Advanced Thyroid Cancers.
    Thyroid. 2022 Mar 9. doi: 10.1089/thy.2021.0542.
    >> Share

  223. YEO Y, Shin DW, Han K, Kim D, et al
    Smoking, alcohol consumption, and the risk of thyroid cancer: a population-based Korean cohort study of 10 million people.
    Thyroid. 2022 Mar 2. doi: 10.1089/thy.2021.0675.
    >> Share

  224. MURI R, Trippel M, Borner U, Weidner SE, et al
    The impact of rapid on-site evaluation (ROSE) on the quality and diagnostic value of thyroid nodule fine-needle aspirations.
    Thyroid. 2022 Mar 2. doi: 10.1089/thy.2021.0551.
    >> Share

  225. MATSUURA D, Yuan A, Wang L, Ranganath R, et al
    Follicular and Hurthle Cell Carcinoma: Comparison of Clinicopathological Features and Clinical Outcomes.
    Thyroid. 2022;32:245-254.
    >> Share

  226. SIMOES-PEREIRA J, C Ferreira T, Limbert E, Cavaco BM, et al
    Response to "Radioiodine Is Molecular Radiotherapy Governed by Predictable Deterministic Radiobiology Expressed in Gray, Not Millicuries" by Kao.
    Thyroid. 2022;32:342-343.
    >> Share

  227. KAO YH
    Letter to the Editor: Radioiodine Is Molecular Radiotherapy Governed by Predictable Deterministic Radiobiology Expressed in Gray, Not Millicuries.
    Thyroid. 2022;32:340-341.
    >> Share

  228. SUZUKI N, Watanabe N, Noh JY, Yoshimura R, et al
    The relationship between primary thyroid lymphoma and various types of thyroid autoimmunity: A retrospective cohort study of 498 cases, including 9 cases with Graves' disease.
    Thyroid. 2022 Mar 1. doi: 10.1089/thy.2021.0613.
    >> Share

  229. HOANG JK, Asadollahi S, Durante C, Hegedus L, et al
    An International Survey on Utilization of Five Thyroid Nodule Risk Stratification Systems: A Needs Assessment with Future Implications.
    Thyroid. 2022 Mar 1. doi: 10.1089/thy.2021.0558.
    >> Share

  230. BLOMAIN ES, Berta S, Hug NF, Giao DM, et al
    Radiotherapy for brain metastases from thyroid cancer: an institutional and national retrospective cohort study.
    Thyroid. 2022 Mar 1. doi: 10.1089/thy.2021.0628.
    >> Share

    February 2022
  231. HSIAO V, Arroyo N, Fernandes-Taylor S, Chiu AS, et al
    Sensitivity of Palpation for Detection of Thyroid Nodules with Attention to Size.
    Thyroid. 2022 Feb 25. doi: 10.1089/thy.2021.0692.
    >> Share

  232. JONKLAAS J
    Impact of Nasolacrimal Dysfunction in Thyroid Cancer Survivors.
    Thyroid. 2022 Feb 18. doi: 10.1089/thy.2022.0095.
    >> Share

  233. GROUSSIN L, Theodon H, Bessiene L, Bricaire L, et al
    Redifferentiating effect of larotrectinib in NTRK-rearranged advanced radioactive-iodine refractory thyroid cancer.
    Thyroid. 2022 Feb 16. doi: 10.1089/thy.2021.0524.
    >> Share

  234. MEGWALU U, Moon PK
    Thyroid Cancer Incidence and Mortality Trends in the United States: 2000 - 2018.
    Thyroid. 2022 Feb 8. doi: 10.1089/thy.2021.0662.
    >> Share

    January 2022
  235. CHOU R, Dana T, Haymart MR, Leung AM, et al
    Active surveillance versus thyroid surgery for differentiated thyroid cancer: A systematic review.
    Thyroid. 2022 Jan 26. doi: 10.1089/thy.2021.0539.
    >> Share

  236. PASQUAL E, Sosa JA, Chen Y, Schonfeld SJ, et al
    Trends in the management of localized papillary thyroid cancer in the United States (2000-2018).
    Thyroid. 2022 Jan 25. doi: 10.1089/thy.2021.0557.
    >> Share

  237. TCHEKMEDYIAN V, Dunn L, Sherman EJ, Baxi SS, et al
    Enhancing Radioiodine Incorporation in BRAF-Mutant, Radioiodine-Refractory Thyroid Cancers with Vemurafenib and the Anti-ErbB3 Monoclonal Antibody CDX-3379: Results of a Pilot Clinical Trial.
    Thyroid. 2022 Jan 19. doi: 10.1089/thy.2021.0565.
    >> Share

  238. STAGNARO-GREEN A
    Thyroid Disease in Pregnancy: A Touch of Clarity.
    Thyroid. 2022 Jan 12. doi: 10.1089/thy.2021.0668.
    >> Share

  239. SAWKA AM, Ghai S, Rotstein L, Irish JC, et al
    A quantitative analysis examining patients' choice of active surveillance or surgery for managing low risk papillary thyroid cancer.
    Thyroid. 2022 Jan 12. doi: 10.1089/thy.2021.0485.
    >> Share

  240. PIERANNUNZIO D, Fedeli U, Francisci S, De Paoli A, et al
    Thyroidectomies in Italy: A population-based national analysis from 2001 to 2018.
    Thyroid. 2022 Jan 12. doi: 10.1089/thy.2021.0531.
    >> Share

    December 2021
  241. SHOBAB L, Burman KD, Wartofsky L
    Sex Differences in Differentiated Thyroid Cancer.
    Thyroid. 2021 Dec 31. doi: 10.1089/thy.2021.0361.
    >> Share

  242. HESS J, Newbern DK, Beebe KL, Walsh AM, et al
    High prevalence of gene fusions and copy number alterations in pediatric radiation therapy-induced papillary and follicular thyroid carcinomas.
    Thyroid. 2021 Dec 16. doi: 10.1089/thy.2021.0217.
    >> Share

  243. SHIN A, Cho S, Jang D, Abe SK, et al
    Body mass index and thyroid cancer risk - A pooled analysis of half a million men and women in the Asia Cohort Consortium.
    Thyroid. 2021 Dec 16. doi: 10.1089/thy.2021.0445.
    >> Share

  244. MEHTA V, Naraparaju A, Liao D, Davies L, et al
    What's in a Name? A Cost-Effectiveness Analysis of the Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP) Nomenclature Revision.
    Thyroid. 2021 Dec 16. doi: 10.1089/thy.2021.0486.
    >> Share

  245. MOLLEN K, Shaffer AD, Yip L, Monaco S, et al
    Unique Molecular Signatures are Associated with Aggressive Histology in Pediatric Differentiated Thyroid Cancer.
    Thyroid. 2021 Dec 16. doi: 10.1089/thy.2021.0317.
    >> Share

  246. LIWEN L, Xinguang Q
    Safety and efficacy of ultrasound-guided radiofrequency ablation for benign nonfunctional thyroid nodules in children: a retrospective study of 62 patients with over 4 years of follow-up.
    Thyroid. 2021 Dec 16. doi: 10.1089/thy.2021.0454.
    >> Share

  247. LEE JY, Woo KI
    Surgical risk prediction for nasolacrimal duct obstruction in radioactive iodine treated thyroid cancer: A nationwide cohort study.
    Thyroid. 2021 Dec 12. doi: 10.1089/thy.2021.0418.
    >> Share

  248. MATSUURA D, Yuan A, Harries V, Shaha AR MD, et al
    Surgical Management of Low-/Intermediate-Risk Node Negative Thyroid Cancer: A Single-Institution Study Using Propensity Matching Analysis to Compare Thyroid Lobectomy and Total Thyroidectomy.
    Thyroid. 2021 Dec 3. doi: 10.1089/thy.2021.0356.
    >> Share

    November 2021
  249. BISCHOFF L, Haymart MR
    Optimal TSH following lobectomy for papillary thyroid cancer: Does it exist?
    Thyroid. 2021 Nov 22. doi: 10.1089/thy.2021.0617.
    >> Share

  250. DI CRISTOFANO A
    The Year in Basic Thyroid Cancer Research.
    Thyroid. 2021 Nov 22. doi: 10.1089/thy.2021.0561.
    >> Share

  251. HAYMART MR
    Year in Thyroidology- Recent Developments and Future Challenges: Clinical Science Review.
    Thyroid. 2021 Nov 22. doi: 10.1089/thy.2021.0562.
    >> Share

  252. JONGEJAN RMS, van Velsen EFS, Meima ME, Klein T, et al
    Change in Thyroid Hormone Metabolite concentrations across Different Thyroid States.
    Thyroid. 2021 Nov 22. doi: 10.1089/thy.2021.0453.
    >> Share

  253. ROBENSHTOK E, Neeman B, Reches L, Ritter A, et al
    Adverse Histological Features of Differentiated Thyroid Cancer are Commonly Found in Autopsy Studies: Implications for Treatment Guidelines.
    Thyroid. 2021 Nov 13. doi: 10.1089/thy.2021.0268.
    >> Share

  254. SHIMURA H, Matsuzuka T, Suzuki S, Iwadate M, et al
    Fine Needle Aspiration Cytology Implementation and Malignancy Rates in Children and Adolescents Based on Japanese Guidelines: The Fukushima Health Management Survey.
    Thyroid. 2021;31:1683-1692.
    >> Share

    October 2021
  255. BARAN J, Bauer AJ, Halada SJ, Mostoufi-Moab S, et al
    Clinical Course of Early Postoperative Hypothyroidism Following Thyroid Lobectomy in Pediatrics.
    Thyroid. 2021 Oct 29. doi: 10.1089/thy.2021.0396.
    >> Share

  256. NEWMAN SK, Harries V, Wang LY, McGill MR, et al
    Invasion of a Recurrent Laryngeal Nerve from Small, Well-Differentiated Papillary Thyroid Cancers: Patient Selection Implications for Active Surveillance.
    Thyroid. 2021 Oct 29. doi: 10.1089/thy.2021.0310.
    >> Share

  257. MONTI S, Presciuttini F, Deiana MG, Motta C, et al
    Cortisol deficiency in Lenvatinib treatment of thyroid cancer: an underestimated, common adverse event.
    Thyroid. 2021 Oct 19. doi: 10.1089/thy.2021.0040.
    >> Share

  258. BERTOL BC, Bales ES, Calhoun JD, Mayberry A, et al
    Lenvatinib plus Anti-PD-1 Combination Therapy for Advanced Cancers: Defining Mechanisms of Resistance in an Inducible Transgenic Model of Thyroid Cancer.
    Thyroid. 2021 Oct 12. doi: 10.1089/thy.2021.0371.
    >> Share

  259. PITT SC, Saucke MC, Roman BR, Alexander SC, et al
    The Influence of Emotions on Treatment Decisions about Low-Risk Thyroid Cancer: A Qualitative Study.
    Thyroid. 2021 Oct 12. doi: 10.1089/thy.2021.0323.
    >> Share

  260. BALLAL S, Yadav MP, Moon ES, Roesch F, et al
    Novel Fibroblast Activation Protein Inhibitor-Based targeted Theranostics for Radioiodine Refractory differentiated Thyroid Cancer Patients: A Pilot Study.
    Thyroid. 2021 Oct 12. doi: 10.1089/thy.2021.0412.
    >> Share

  261. XU S, Huang Y, Huang H, Zhang X, et al
    Optimal serum thyroid-stimulating hormone level for patients with papillary thyroid carcinoma after lobectomy.
    Thyroid. 2021 Oct 7. doi: 10.1089/thy.2021.0404.
    >> Share

  262. HUANG NS, Wei WJ, Xiang J, Chen JY, et al
    The Efficacy and Safety of Anlotinib in Neoadjuvant Treatment of Locally Advanced Thyroid Cancer: A Single-arm Phase II Clinical Trial.
    Thyroid. 2021 Oct 6. doi: 10.1089/thy.2021.0307.
    >> Share

  263. RANA C, Vuong HG, Nguyen TQ, Nguyen HC, et al
    The Incidence of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features: A Meta-Analysis Assessing Worldwide Impact of the Reclassification.
    Thyroid. 2021;31:1502-1513.
    >> Share

    September 2021
  264. SUGINO K, Nagahama M, Kitagawa W, Ohkuwa K, et al
    Cutoff age between pediatric and adult thyroid differentiated cancer: Is 18 years old appropriate?
    Thyroid. 2021 Sep 22. doi: 10.1089/thy.2021.0255.
    >> Share

  265. FORLEO R, Grani G, Alfo M, Zilioli V, et al
    Minimal Extrathyroidal Extension in Predicting 1-Year Outcomes: A Longitudinal Multicenter Study of Low-to-Intermediate-Risk Papillary Thyroid Carcinoma (ITCO#4).
    Thyroid. 2021 Sep 19. doi: 10.1089/thy.2021.0248.
    >> Share

  266. SATO A, Tanabe M, Tsuboi Y, Niwa T, et al
    Circulating tumor DNA harboring the BRAF V600E mutation may predict poor outcomes of primary papillary thyroid cancer patients.
    Thyroid. 2021 Sep 19. doi: 10.1089/thy.2021.0267.
    >> Share

  267. DEKKER BL, Muller Kobold AC, Brouwers AH, Williams GRR, et al
    Bone Mineral Density in Adult Survivors of Pediatric Differentiated Thyroid Carcinoma: a longitudinal follow-up study.
    Thyroid. 2021 Sep 13. doi: 10.1089/thy.2021.0179.
    >> Share

  268. GUO K, Qian K, Shi Y, Sun T, et al
    Clinical and Molecular Characterizations of Papillary Thyroid Cancer in Children and Young Adults: a Multicenter Retrospective Study.
    Thyroid. 2021 Sep 13. doi: 10.1089/thy.2021.0003.
    >> Share

  269. TESSLER FN
    American Thyroid Association Non-Classifiable Thyroid Nodules: A New Perspective.
    Thyroid. 2021 Sep 2. doi: 10.1089/thy.2021.0449.
    >> Share

  270. MA T, Semsarian CR, Barratt A, Parker L, et al
    Rethinking low risk micropapillary thyroid cancer: an evidence review for recalibrating diagnostic thresholds and/or alternative labels.
    Thyroid. 2021 Sep 2. doi: 10.1089/thy.2021.0274.
    >> Share

  271. HO AS, Luu M, Shafqat I, Mallen-St Clair J, et al
    Predictive impact of metastatic lymph node burden on distant metastasis across papillary thyroid cancer variants.
    Thyroid. 2021 Sep 2. doi: 10.1089/thy.2021.0131.
    >> Share

    August 2021
  272. KIM HJ, Chung SM, Kim H, Jang JY, et al
    Long-term efficacy of ultrasound-guided laser ablation for papillary thyroid microcarcinoma: Results of a 10-year retrospective study.
    Thyroid. 2021 Aug 27. doi: 10.1089/thy.2021.0151.
    >> Share

  273. KOEHLER VF, Berg E, Adam P, Weber GL, et al
    Real world efficacy and safety of multi-tyrosine kinase inhibitors in radioiodine refractory thyroid cancer.
    Thyroid. 2021 Aug 18. doi: 10.1089/thy.2021.0091.
    >> Share

  274. GROUSSIN L, Bessiene L, Arrondeau J, Garinet S, et al
    Selpercatinib-Enhanced Radioiodine Uptake in RET-Rearranged Thyroid Cancer.
    Thyroid. 2021 Aug 18. doi: 10.1089/thy.2021.0144.
    >> Share

  275. XU S, Huang H, Zhang X, Huang Y, et al
    Predictive value of serum thyroglobulin for structural recurrence following lobectomy for papillary thyroid carcinoma.
    Thyroid. 2021 Aug 3. doi: 10.1089/thy.2021.0209.
    >> Share

  276. FIGGE JJ, Gooding WE, Steward DL, Yip L, et al
    Do Ultrasound Patterns and Clinical Parameters Inform the Probability of Thyroid Cancer Predicted by Molecular Testing in Nodules with Indeterminate Cytology?
    Thyroid. 2021 Aug 3. doi: 10.1089/thy.2021.0119.
    >> Share

  277. PIEK MW, de Boer JP, Vriens MR, van Leeuwaarde RS, et al
    Retrospective analyses of 18FDG-PET/CT thyroid incidentaloma in adults: incidence, treatment and outcome in a tertiary cancer referral center.
    Thyroid. 2021 Aug 3. doi: 10.1089/thy.2021.0226.
    >> Share

    July 2021
  278. KOBALY K, Kim CS, Langer JE, Mandel SJ, et al
    Macrocalcifications Do Not Alter Malignancy Risk Within the American Thyroid Association Sonographic Pattern System When Present in Non-High Suspicion Thyroid Nodules.
    Thyroid. 2021 Jul 27. doi: 10.1089/thy.2021.0140.
    >> Share

  279. OKAZAKI-HADA M, Maruoka A, Yamamoto M, Ito M, et al
    Poorly differentiated thyroid carcinoma coexisting with Graves' disease involving T3 thyrotoxicosis due to increased D1 and D2 activities.
    Thyroid. 2021 Jul 18. doi: 10.1089/thy.2021.0082.
    >> Share

  280. YAN L, Zhang M, Song Q, Luo Y, et al
    Ultrasound-Guided Radiofrequency Ablation Versus Thyroid Lobectomy for Low-Risk Papillary Thyroid Microcarcinoma: A Propensity-matched Cohort Study of 884 Patients.
    Thyroid. 2021 Jul 16. doi: 10.1089/thy.2021.0100.
    >> Share

  281. JIN M, Kim HI, Ha J, Jeon MJ, et al
    Tumor Volume Doubling Time in Active Surveillance of Papillary Thyroid Microcarcinoma: A Multicenter Cohort Study in Korea.
    Thyroid. 2021 Jul 6. doi: 10.1089/thy.2021.0094.
    >> Share

    June 2021
  282. SIMOES-PEREIRA J, C Ferreira T, Limbert E, Cavaco BM, et al
    Outcomes of thyrotropin alfa vs. levothyroxine withdrawal-aided radioiodine therapy for distant metastasis of papillary thyroid cancer.
    Thyroid. 2021 Jun 22. doi: 10.1089/thy.2021.0013.
    >> Share

  283. RYDER M, Wentworth M, Algeciras-Schimnich A, Morris JC 3rd, et al
    Blocking the TSH receptor with K1-70 in a patient with follicular thyroid cancer, Graves' disease and Graves' ophthalmopathy.
    Thyroid. 2021 Jun 11. doi: 10.1089/thy.2021.0053.
    >> Share

  284. GRONLUND MP, Schmidt Jensen J, Hahn CH, Gronhoj C, et al
    Risk factors for recurrence of follicular thyroid cancer: A systematic review.
    Thyroid. 2021 Jun 9. doi: 10.1089/thy.2020.0921.
    >> Share

  285. EGAN CE, Stefanova D, Ahmed A, Raja VJ, et al
    CSPG4 is a Potential Therapeutic Target in Anaplastic Thyroid Cancer.
    Thyroid. 2021 Jun 3. doi: 10.1089/thy.2021.0067.
    >> Share

    May 2021
  286. BUNEVICIUS A, Fribance S, Pikis S, Lee JYK, et al
    Stereotactic Radiosurgery for Differentiated Thyroid Cancer Brain Metastases: An International, Multicenter Study.
    Thyroid. 2021 May 11. doi: 10.1089/thy.2020.0947.
    >> Share

    April 2021
  287. KIM DH, Kim SW, Kang P, Choi J, et al
    Near-infrared autofluorescence imaging may reduce temporary hypoparathyroidism in patients undergoing total thyroidectomy and central neck dissection.
    Thyroid. 2021 Apr 28. doi: 10.1089/thy.2021.0056.
    >> Share

  288. MARQUES IJ, Gomes I, Pojo M, Pires C, et al
    Identification of SPRY4 as a novel candidate susceptibility gene for familial non-medullary thyroid cancer.
    Thyroid. 2021 Apr 28. doi: 10.1089/thy.2020.0290.
    >> Share

  289. LUBITZ CC, Sadow PM, Daniels GH, Wirth LJ, et al
    Progress in Treating Advanced Thyroid Cancers in the Era of Targeted Therapy.
    Thyroid. 2021 Apr 16. doi: 10.1089/thy.2020.0962.
    >> Share

  290. VUONG HG, Jung CK, Kakudo K, Bychkov A, et al
    Response to Cherella et al. re: "The use of The Bethesda System for Reporting Thyroid Cytopathology in Pediatric Thyroid Nodules: a meta-analysis".
    Thyroid. 2021 Apr 15. doi: 10.1089/thy.2021.0190.
    >> Share

  291. LEE SB, Cho YJ, Lee S, Choi YH, et al
    Korean Society of Thyroid Radiology (KSThR) guidelines for the management of pediatric thyroid nodules: Suitability and risk factors.
    Thyroid. 2021 Apr 9. doi: 10.1089/thy.2020.0875.
    >> Share

  292. CHERELLA CE, Cibas ES, Wassner AJ
    Re: "The use of the Bethesda System for Reporting Thyroid Cytopathology in pediatric thyroid nodules - A meta-analysis" by Vuong, et al.
    Thyroid. 2021 Apr 5. doi: 10.1089/thy.2021.0116.
    >> Share

  293. NISHINO M, Mateo R, Kilim H, Feldman A, et al
    Repeat Fine Needle Aspiration Cytology Refines the Selection of Thyroid Nodules for Afirma Gene Expression Classifier Testing.
    Thyroid. 2021 Apr 3. doi: 10.1089/thy.2020.0969.
    >> Share

  294. KAYA C, Dorsaint P, Mercurio S, Campbell AM, et al
    Limitations of Detecting Genetic Variants from the RNA Sequencing Data in Tissue and Fine-Needle Aspiration Samples.
    Thyroid. 2021;31:589-595.
    >> Share

  295. GULEC SA, Ahuja S, Avram A, Bernet V, et al
    A JOINT STATEMENT FROM THE AMERICAN THYROID ASSOCIATION, THE EUROPEAN ASSOCIATION OF NUCLEAR MEDICINE, THE EUROPEAN THYROID ASSOCIATION, THE SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING ON CURRENT DIAGNOSTIC AND THERANOSTIC APPROACHES IN THE MANA
    Thyroid. 2021 Apr 1. doi: 10.1089/thy.2020.0826.
    >> Share

    March 2021
  296. PAPALEONTIOU M, Chen D, Banerjee M, Reyes-Gastelum D, et al
    TSH Suppression for Papillary Thyroid Cancer: A Physician Survey Study.
    Thyroid. 2021 Mar 27. doi: 10.1089/thy.2021.0033.
    >> Share

  297. GORTAKOWSKI M, Feghali K, Osakwe IN
    SINGLE INSTITUTION EXPERIENCE WITH AFIRMA AND THYROSEQ TESTING IN INDETERMINATE THYROID NODULES.
    Thyroid. 2021 Mar 25. doi: 10.1089/thy.2020.0801.
    >> Share

  298. PAPALEONTIOU M, Norton EC, Reyes-Gastelum D, Banerjee M, et al
    Competing Causes of Death in Older Adults with Thyroid Cancer.
    Thyroid. 2021 Mar 25. doi: 10.1089/thy.2020.0929.
    >> Share

  299. BIBLE KC, Kebebew E, Brierley J, Brito JP, et al
    2021 American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer.
    Thyroid. 2021;31:337-386.
    >> Share

    February 2021
  300. TAYLOR MH, Takahashi S, Capdevila J, Tahara M, et al
    Correlation of Performance Status and Neutrophil-Lymphocyte Ratio With Efficacy in Radioiodine-Refractory Differentiated Thyroid Cancer Treated With Lenvatinib.
    Thyroid. 2021 Feb 26. doi: 10.1089/thy.2020.0779.
    >> Share

  301. MATHEW A, Latteyer S, Frank-Raue K, Moeller LC, et al
    A Novel Double RET E768D/L790F Mutation Associated with a MEN2B-Like Phenotype.
    Thyroid. 2021;31:327-329.
    >> Share

  302. GRANI G, Zatelli MC, Alfo M, Montesano T, et al
    Real-World Performance of the American Thyroid Association Risk Estimates in Predicting 1-Year Differentiated Thyroid Cancer Outcomes: A Prospective Multicenter Study of 2000 Patients.
    Thyroid. 2021;31:264-271.
    >> Share

    January 2021
  303. VUONG HGG, Chung DGB, Ngo LM, Bui TQ, et al
    The use of the Bethesda system for reporting thyroid cytopathology in pediatric thyroid nodules - A meta-analysis.
    Thyroid. 2021 Jan 27. doi: 10.1089/thy.2020.0702.
    >> Share

  304. VAN VELSEN EFS, Visser WE, Stegenga MT, Maeder U, et al
    Finding the Optimal Age Cutoff for the UICC/AJCC TNM Staging System in Patients with Papillary or Follicular Thyroid Cancer.
    Thyroid. 2021 Jan 23. doi: 10.1089/thy.2020.0615.
    >> Share

  305. MORARIU EM, McCoy KL, Chiosea SI, Nikitski AV, et al
    Clinicopathologic Characteristics of Thyroid Nodules Positive for the THADA-IGF2BP3 Fusion on Preoperative Molecular Analysis.
    Thyroid. 2021 Jan 23. doi: 10.1089/thy.2020.0589.
    >> Share

  306. LONCAR I, van Dijk SPJ, Metman MJH, Lin JF, et al
    Active surveillance for papillary thyroid microcarcinoma in a population with restrictive diagnostic work-up strategies.
    Thyroid. 2021 Jan 11. doi: 10.1089/thy.2020.0845.
    >> Share

    December 2020
  307. CONDELLO V, Nikitski AV, Foulkes W, Nikiforov YE, et al
    Prevalence of WWP1 Gene Mutations in Patients with Thyroid Nodules.
    Thyroid. 2020 Dec 29. doi: 10.1089/thy.2020.0919.
    >> Share

  308. NG DL, van Zante A, Griffin A, Hills NK, et al
    A large thyroid fine needle aspiration biopsy cohort with long-term population-based follow-up.
    Thyroid. 2020 Dec 28. doi: 10.1089/thy.2020.0689.
    >> Share

  309. CHUNG SR, Choi YJ, Lee SS, Kim SO, et al
    Interobserver Reproducibility in Sonographic Measurement of Diameter and Volume of Papillary Thyroid Microcarinoma.
    Thyroid. 2020 Dec 7. doi: 10.1089/thy.2020.0317.
    >> Share

  310. TOUMI A, DiGennaro C, Vahdat V, Jalali M, et al
    Trends in Thyroid Surgery and Guideline-Concordant Care in the United States, 2007-2018.
    Thyroid. 2020 Dec 5. doi: 10.1089/thy.2020.0643.
    >> Share

    November 2020
  311. KANG YE, Kim JM, Lim MA, Lee SE, et al
    Growth differentiation factor 15 is a cancer cell-induced mitokine that primes thyroid cancer cells for invasiveness.
    Thyroid. 2020 Nov 30. doi: 10.1089/thy.2020.0034.
    >> Share

  312. SHIH P, Nickel B, Degeling C, Thomas R, et al
    Terminology change for small low-risk papillary thyroid cancer as a response to overtreatment: Results from three Australian community juries.
    Thyroid. 2020 Nov 25. doi: 10.1089/thy.2020.0694.
    >> Share

  313. LORUSSO L, Romei C, Piaggi P, Fustini C, et al
    Ca19.9 positivity and doubling time are prognostic factors of mortality in patients with advanced medullary thyroid cancer with no evidence of structural disease progression according to RECIST.
    Thyroid. 2020 Nov 24. doi: 10.1089/thy.2020.0060.
    >> Share

  314. LANDA I
    PLEKHS1 mutations in thyroid cancers.
    Thyroid. 2020 Nov 15. doi: 10.1089/thy.2020.0728.
    >> Share

  315. CIAPPUCCINI R, Licaj I, Lasne-Cardon A, Babin E, et al
    18F-Fluorocholine PET/CT is a highly sensitive but poorly specific tool for identifying malignancy in thyroid nodules with indeterminate cytology: The Chocolate study.
    Thyroid. 2020 Nov 12. doi: 10.1089/thy.2020.0555.
    >> Share

  316. RAMIREZ-MOYA J, Santisteban P
    A positive feedback loop between DICER1 and differentiation transcription factors is important for thyroid tumorigenesis.
    Thyroid. 2020 Nov 11. doi: 10.1089/thy.2020.0297.
    >> Share

  317. LARCHER DE ALMEIDA AM, Delfim RLC, Vidal APA, Chaves MCDACM, et al
    Combining the American Thyroid Association's ultrasound classification with cytological subcategorization improves the assessment of malignancy risk in indeterminate thyroid nodules.
    Thyroid. 2020 Nov 4. doi: 10.1089/thy.2019.0575.
    >> Share

  318. GUO J, Teng D, Shi X, Li Y, et al
    Exposure to the Chinese Great Famine in early life and thyroid function and disorders in adulthood: a cross-sectional study.
    Thyroid. 2020 Nov 2. doi: 10.1089/thy.2020.0325.
    >> Share

    October 2020
  319. JANMOHAMED N, Segal P, Corrado A, Lofters A, et al
    Endocrinologist perceived factors affecting the transition of thyroid cancer patients from specialist to primary care post-cancer treatment in Ontario, Canada.
    Thyroid. 2020 Oct 29. doi: 10.1089/thy.2020.0413.
    >> Share

  320. LEE YA, Yun HR, Lee J, Moon H, et al
    Trends in Pediatric Thyroid Cancer Incidence, Treatment, and Clinical Course in Korea during 2004-2016: A Nationwide Population-Based Study.
    Thyroid. 2020 Oct 27. doi: 10.1089/thy.2020.0155.
    >> Share

  321. SUGITANI I, Ito Y, Takeuchi D, Nakayama H, et al
    Indications and strategy for active surveillance of adult low-risk papillary thyroid microcarcinoma: consensus statements from the Japan Association of Endocrine Surgery task force on management for papillary thyroid microcarcinoma.
    Thyroid. 2020 Oct 6. doi: 10.1089/thy.2020.0330.
    >> Share

  322. PITT SC, Saucke MC, Wendt EM, Schneider DF, et al
    Patients' Reaction to Diagnosis with Thyroid Cancer or an Indeterminate Thyroid Nodule.
    Thyroid. 2020 Oct 3. doi: 10.1089/thy.2020.0233.
    >> Share

  323. PIEK MW, Postma EL, van Leeuwaarde R, de Boer JP, et al
    The effect of radioactive iodine therapy on ovarian function and fertility in female thyroid cancer patients: a systematic review and meta-analysis.
    Thyroid. 2020 Oct 3. doi: 10.1089/thy.2020.0356.
    >> Share

  324. TRAVERSI F, Stooss A, Dettmer MS, Charles RP, et al
    BRAFV600E overrides NOTCH signaling in thyroid cancer.
    Thyroid. 2020 Oct 3. doi: 10.1089/thy.2019.0595.
    >> Share

    September 2020
  325. GIANI C, Valerio L, Bongiovanni A, Durante C, et al
    Safety and quality of life data from an Italian expanded access program of lenvatinib for treatment of thyroid cancer.
    Thyroid. 2020 Sep 10. doi: 10.1089/thy.2020.0276.
    >> Share

  326. DEZIEL N, Zhang Y, Wang R, Wiemels J, et al
    Birth Characteristics and Risk of Pediatric Thyroid Cancer: A Population-Based Record-Linkage Study in California.
    Thyroid. 2020 Sep 10. doi: 10.1089/thy.2020.0217.
    >> Share

  327. YANSONG L, Yang H, Ding Y, Cheng Y, et al
    Donafenib in progressive locally advanced or metastatic radioactive iodine-refractory differentiated thyroid cancer: results of a randomized, multicenter, phase II trial.
    Thyroid. 2020 Sep 10. doi: 10.1089/thy.2020.0235.
    >> Share

    August 2020
  328. CHEN D, Reyes-Gastelum D, Veenstra CM, Hamilton AS, et al
    Financial hardship among Hispanic women with thyroid cancer.
    Thyroid. 2020 Aug 25. doi: 10.1089/thy.2020.0497.
    >> Share

  329. JACOBS D, Breen CT, Pucar D, Holt E, et al
    Changes in Population-Level and Institutional-Level Prescribing Habits of Radioiodine Therapy for Papillary Thyroid Cancer.
    Thyroid. 2020 Aug 18. doi: 10.1089/thy.2020.0237.
    >> Share

  330. SHIN HS, Sun HJ, Whang YM, Park YJ, et al
    Metformin reduces thyroid cancer tumor growth in the metastatic niche of bone by inhibiting osteoblastic RANKL productions.
    Thyroid. 2020 Aug 13. doi: 10.1089/thy.2019.0851.
    >> Share

  331. ZHAO CK, Ren TT, Yin YF, Shi H, et al
    A Comparative Analysis of Two Machine Learning-based Diagnostic Patterns with ACR TI-RADS for Thyroid Nodules: Diagnostic Performance and Unnecessary Biopsy Rate.
    Thyroid. 2020 Aug 11. doi: 10.1089/thy.2020.0305.
    >> Share

  332. KOEHLER V, Adam P, Frank-Raue K, Raue F, et al
    Real world efficacy and safety of cabozantinib and vandetanib in advanced medullary thyroid cancer.
    Thyroid. 2020 Aug 11. doi: 10.1089/thy.2020.0206.
    >> Share

  333. HEGEDUS L, Miyauchi A, Tuttle RM
    Non-surgical thermal ablation of thyroid nodules. Not if, but why, when, and how?
    Thyroid. 2020 Aug 10. doi: 10.1089/thy.2020.0659.
    >> Share

  334. ALLOCCA C, Cirafici AM, Laukkanen MO, Castellone MD, et al
    Serine 897 phosphorylation of EPHA2 is involved in signaling of oncogenic ERK1/2 drivers in thyroid cancer cells.
    Thyroid. 2020 Aug 6. doi: 10.1089/thy.2019.0728.
    >> Share

    July 2020
  335. AGATE L, Puleo L, Giani C, Valerio L, et al
    Symptomatic and asymptomatic biliary disorders during lenvatinib treatment for advanced thyroid cancer is an underestimated problem.
    Thyroid. 2020 Jul 29. doi: 10.1089/thy.2020.0245.
    >> Share

  336. MAINO F, Bufano A, Dalmazio G, Campanile M, et al
    VALIDATION OF AMERICAN THYROID ASSOCIATION ULTRASOUND RISK-ADAPTED APPROACH FOR REPEATING CYTOLOGY IN BENIGN THYROID NODULES.
    Thyroid. 2020 Jul 27. doi: 10.1089/thy.2020.0351.
    >> Share

  337. HERNANDEZ-PRERA J, Valderrabano P, Creed J, de la Iglesia JV, et al
    MOLECULAR DETERMINANTS OF THYROID NODULES WITH INDETERMINATE CYTOLOGY AND RAS MUTATIONS.
    Thyroid. 2020 Jul 21. doi: 10.1089/thy.2019.0650.
    >> Share

  338. SASAKI T, Miyauchi A, Ito Y, Kudo T, et al
    Marked decrease over time in conversion surgery after active surveillance of low-risk papillary thyroid microcarcinoma.
    Thyroid. 2020 Jul 14. doi: 10.1089/thy.2020.0319.
    >> Share

  339. BRUCE JY, Bible KC, Chintakuntlawar A
    Emergence of resistant clones in medullary thyroid cancer may not be rescued by subsequent salvage highly selective RET-inhibitor therapy.
    Thyroid. 2020 Jul 14. doi: 10.1089/thy.2020.0449.
    >> Share

  340. YOON JH, Hong AR, Kim HK, Kang HC, et al
    Anaplastic Thyroid Cancer Arising from Dyshormonogenetic Goiter: c.3070T>C and Novel c.7070T>C Mutation in the Thyroglobulin Gene.
    Thyroid. 2020 Jul 6. doi: 10.1089/thy.2020.0248.
    >> Share

  341. AHN J, Jin M, Song E, Ryu YM, et al
    Immune profiling of advanced thyroid cancers using fluorescent multiplex immunohistochemistry.
    Thyroid. 2020 Jul 1. doi: 10.1089/thy.2020.0312.
    >> Share

    June 2020
  342. BERNARDI S, Giudici F, Cesareo R, Antonelli G, et al
    Five-year results of radiofrequency and laser ablation of benign thyroid nodules: a multicenter study from the Italian minimally-invasive treatments of the thyroid group.
    Thyroid. 2020 Jun 24. doi: 10.1089/thy.2020.0202.
    >> Share

  343. CHUNG R, Guan H, Ponchiardi C, Cerda SR, et al
    Noninvasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features (NIFTP): Epidemiology and Long-Term Outcomes in a Strictly-Defined Cohort.
    Thyroid. 2020 Jun 16. doi: 10.1089/thy.2019.0616.
    >> Share

  344. BIBLE KC, Menefee ME, Lin CC, Millward M, et al
    An International Phase 2 Study of Pazopanib in Progressive and Metastatic Thyroglobulin Antibody Negative Radioactive Iodine Refractory Differentiated Thyroid Cancer.
    Thyroid. 2020 Jun 14. doi: 10.1089/thy.2019.0269.
    >> Share

  345. PARK JH, Choi M, Kim JH, Kim J, et al
    Metabolic syndrome and the risk of thyroid cancer: A nationwide population-based cohort study.
    Thyroid. 2020 Jun 11. doi: 10.1089/thy.2019.0699.
    >> Share

  346. CERIANI L, Milan L, Virili C, Cascione L, et al
    Radiomics analysis of [18F] fluorodeoxyglucose-avid thyroid incidentalomas improves risk stratification and selection for clinical assessment.
    Thyroid. 2020 Jun 10. doi: 10.1089/thy.2020.0224.
    >> Share

  347. CHESOVER AD, Vali R, Hemmati SH, Wasserman JD, et al
    Lung metastasis in children with differentiated thyroid cancer: factors associated with diagnosis and outcomes of therapy.
    Thyroid. 2020 Jun 10. doi: 10.1089/thy.2020.0002.
    >> Share

  348. ZHU CY, Sha SW, Tseng CH, Yang SE, et al
    Trends in the surgical management of known or suspected differentiated thyroid cancer at a single institution, 2010 - 2018.
    Thyroid. 2020 Jun 9. doi: 10.1089/thy.2019.0783.
    >> Share

  349. GUGNONI M, Manicardi V, Torricelli F, Sauta E, et al
    Linc00941 is a novel TGFbeta target that primes papillary thyroid cancer metastatic behavior by regulating the expression of Cadherin 6.
    Thyroid. 2020 Jun 4. doi: 10.1089/thy.2020.0001.
    >> Share

    May 2020
  350. LEE M, Powers AE, Morris LGT, Marti JL, et al
    Reversal in thyroid cancer incidence trends in the United States, 2000-2017.
    Thyroid. 2020 May 27. doi: 10.1089/thy.2020.0321.
    >> Share

  351. TENG D, Li W, Du J, Wang H, et al
    Effects of MWA on Papillary Thyroid Microcarcinoma: A 5-Year Follow-up Report.
    Thyroid. 2020 May 27. doi: 10.1089/thy.2020.0049.
    >> Share

  352. JEON M, You MH, Han JM, Sim SY, et al
    High phosphoglycerate dehydrogenase expression induces stemness and aggressiveness in thyroid cancer.
    Thyroid. 2020 May 22. doi: 10.1089/thy.2020.0105.
    >> Share

  353. HUGHES E, Rhoads A, Thomas A, Aloi J, et al
    Incidence and Survival in Reproductive-Aged Women with Differentiated Thyroid Cancer: United States SEER18 2000-2016.
    Thyroid. 2020 May 12. doi: 10.1089/thy.2020.0152.
    >> Share

  354. HODAK SP, Duh QY
    The American Association of Endocrine Surgeons (AAES) Guidelines for the Definitive Surgical Management of Thyroid Disease in Adults
    Thyroid. 2020 May 10. doi: 10.1089/thy.2020.0209.
    >> Share

  355. CHO SJ, Baek SM, Lim HK, Lee KD, et al
    Long-term Follow-up Results of Ultrasound-guided Radiofrequency Ablation for Low-risk Papillary Thyroid Microcarcinoma: More than 5 year follow-up for 84 tumors.
    Thyroid. 2020 May 7. doi: 10.1089/thy.2020.0106.
    >> Share

  356. HORVATH E, Skoknic Binder V, Majlis Drinberg S, Tala Jury H, et al
    Radioiodine-induced salivary gland damage detected by ultrasonography in patients treated for papillary thyroid cancer: RAI activity and risk.
    Thyroid. 2020 May 6. doi: 10.1089/thy.2019.0563.
    >> Share

  357. AROSEMENA M, Thekkumkattil A, Linares Valderrama MI, Kuker RA, et al
    American Thyroid Association Sonographic Risk and Afirma Gene Expression Classifier Alone and in Combination for the Diagnosis of Thyroid Nodules with Bethesda Category III Cytology.
    Thyroid. 2020 May 2. doi: 10.1089/thy.2019.0673.
    >> Share

    April 2020
  358. FAZELI SR, Zehr B, Amraei R, Toraldo G, et al
    ThyroSeq v2 Testing: Impact on Cytologic Diagnosis, Management, and Cost of Care in Patients with Thyroid Nodule.
    Thyroid. 2020 Apr 29. doi: 10.1089/thy.2019.0191.
    >> Share

  359. CHEN D, Haymart MR
    Disparities research in thyroid cancer: challenges and strategies for improvement.
    Thyroid. 2020 Apr 28. doi: 10.1089/thy.2020.0166.
    >> Share

  360. LEE ZJO, Eslick GD, Edirimanne S
    Investigating anti-thyroglobulin antibody as a prognostic marker for differentiated thyroid cancer: A Meta-Analysis and Systematic Review.
    Thyroid. 2020 Apr 28. doi: 10.1089/thy.2019.0368.
    >> Share

  361. JUNG CK, Jung SH, Jeon S, Jeong YM, et al
    Risk stratification using a novel genetic classifier including <i>PLEKHS1</i> promoter mutations for differentiated thyroid cancer with distant metastasis.
    Thyroid. 2020 Apr 23. doi: 10.1089/thy.2019.0459.
    >> Share

  362. KOTWAL A, Gustafson M, Bornschlegl S, Kottschade L, et al
    Immune checkpoint inhibitor-induced thyroiditis is associated with increased intrathyroidal T lymphocyte subpopulations.
    Thyroid. 2020 Apr 23. doi: 10.1089/thy.2020.0075.
    >> Share

  363. ROTH EM, Lubitz CC, Swan JS, James BC, et al
    Patient-reported quality of life outcome measures in the thyroid cancer population.
    Thyroid. 2020 Apr 15. doi: 10.1089/thy.2020.0038.
    >> Share

  364. STEPHENSON A, Eszlinger M, Stewardson P, McIntyre JB, et al
    Sensitive sequencing analysis suggests TSHR and GNAS as sole driver mutations in hot thyroid nodules.
    Thyroid. 2020 Apr 13. doi: 10.1089/thy.2019.0648.
    >> Share

  365. MUIR C, Menzies AM, J Clifton-Bligh R, Tsang VHM, et al
    Thyroid toxicity following immune checkpoint inhibitor treatment in advanced cancer.
    Thyroid. 2020 Apr 7. doi: 10.1089/thy.2020.0032.
    >> Share

  366. CHEN T, Gilfix B, Rivera JA, Sadeghi N, et al
    The Role of the ThyroSeq v3 Molecular Test in the Surgical Management of Thyroid Nodules in the Canadian Public Healthcare Setting.
    Thyroid. 2020 Apr 3. doi: 10.1089/thy.2019.0539.
    >> Share

  367. POZDEYEV N, Erickson T, Zhang L, Ellison K, et al
    Comprehensive Immune Profiling of Medullary Thyroid Cancer.
    Thyroid. 2020 Apr 3. doi: 10.1089/thy.2019.0604.
    >> Share

    March 2020
  368. FAUSTINO LC, Li CW, Stefan M, Kim K, et al
    A novel mouse model of autoimmune thyroiditis induced by immunization with adenovirus containing full-length thyroglobulin cDNA: Implications to genetic studies of thyroid autoimmunity.
    Thyroid. 2020 Mar 31. doi: 10.1089/thy.2019.0711.
    >> Share

  369. HONG MJ, Na DG, Lee H
    Diagnostic efficacy and safety of core needle biopsy as a first-line diagnostic method for thyroid nodules: a prospective cohort study.
    Thyroid. 2020 Mar 31. doi: 10.1089/thy.2019.0444.
    >> Share

  370. ENDO M, Nabhan F, Angell TE, Harrell M, et al
    Use of Molecular Diagnostic Tests in Thyroid Nodules with Hurthle Cell-Dominant Cytology.
    Thyroid. 2020 Mar 31. doi: 10.1089/thy.2020.0021.
    >> Share

  371. MCKELVEY BA, Gilpatrick T, Wang Y, Timp W, et al
    Characterization of Allele-Specific Regulation of Telomerase Reverse Transcriptase in Promoter Mutant Thyroid Cancer Cell Lines.
    Thyroid. 2020 Mar 31. doi: 10.1089/thy.2020.0055.
    >> Share

  372. RAHMAN S, Pandeya N, Neale RE, McLeod DSA, et al
    Obesity is associated with BRAF V600E-mutated thyroid cancer.
    Thyroid. 2020 Mar 31. doi: 10.1089/thy.2019.0654.
    >> Share

  373. YIN N, Sherman SI, Pak Y, Litofsky D, et al
    The De novo Detection of Anti-thyroglobulin Antibodies and Differentiated Thyroid Cancer Recurrence.
    Thyroid. 2020 Mar 31. doi: 10.1089/thy.2019.0791.
    >> Share

  374. CABANILLAS M, Dadu R, Iyer PC, Wanland KB, et al
    Acquired secondary RAS mutation in BRAFV600E mutated thyroid cancer patients treated with BRAF inhibitors.
    Thyroid. 2020 Mar 26. doi: 10.1089/thy.2019.0514.
    >> Share

  375. SUKPANICH R, Sanglestsawai S, Seib CD, Gosnell JE, et al
    The influence of cosmetic concerns on patient preferences for approaches to thyroid lobectomy: A discrete choice experiment.
    Thyroid. 2020 Mar 24. doi: 10.1089/thy.2019.0821.
    >> Share

  376. PEPLAU E, De Rose F, Reder S, Mittelhaeuser M, et al
    Development of a chimeric Fab directed against human galectin-3 and validation as an immune-PET tracer for the sensitive in vivo imaging of thyroid cancer.
    Thyroid. 2020 Mar 21. doi: 10.1089/thy.2019.0670.
    >> Share

  377. PAPALEONTIOU M, Evron J, Esfandiari N, Reyes-Gastelum D, et al
    Patient Report of Recurrent and Persistent Thyroid Cancer.
    Thyroid. 2020 Mar 18. doi: 10.1089/thy.2019.0652.
    >> Share

  378. PAPALEONTIOU M, Haymart MR
    Too much of a good thing? A cautionary tale of thyroid cancer overdiagnosis and overtreatment.
    Thyroid. 2020 Mar 11. doi: 10.1089/thy.2020.0185.
    >> Share

  379. LI H, Wang Z, Liu JS, Zou BS, et al
    Association between breast and thyroid lesions: a cross-sectional study based on ultrasonography screening in China.
    Thyroid. 2020 Mar 8. doi: 10.1089/thy.2019.0184.
    >> Share

  380. AHMADI S, Gonzalez Sepulveda JM, Talbott M, Reed S, et al
    Patient preferences around extent of surgery in low-risk thyroid cancer: A discrete-choice experiment.
    Thyroid. 2020 Mar 6. doi: 10.1089/thy.2019.0590.
    >> Share

  381. SAWKA AM, Ghai S, Yoannidis T, Rotstein L, et al
    A prospective mixed-methods study of decision-making on surgery or active surveillance for low risk papillary thyroid cancer.
    Thyroid. 2020 Mar 4. doi: 10.1089/thy.2019.0592.
    >> Share

  382. YEH T, Yeung M, Sherman EJ, Tuttle RM MD, et al
    Structural doubling time predicts overall survival in patients with medullary thyroid cancer in patients with rapidly progressive metastatic medullary thyroid cancer treated with molecular targeted therapies.
    Thyroid. 2020 Mar 4. doi: 10.1089/thy.2019.0579.
    >> Share

  383. KIM M, Kim SJ, Xu Z, Ha SY, et al
    <i>BRAF<sup>V600E</i></sup> Transduction of SV40-immortalized Normal Human Thyroid Cell Line Induces Dedifferentiated Thyroid Carcinogenesis in a Mouse Xenograft Model.
    Thyroid. 2020 Mar 2. doi: 10.1089/thy.2019.0301.
    >> Share

    February 2020
  384. YIP L
    Thoughtful Utilization of Molecular Testing in Refining Thyroid Nodule Risk Assessment: Don't Throw Out the Baby.
    Thyroid. 2020 Feb 28. doi: 10.1089/thy.2020.0148.
    >> Share

  385. JHIANG SM, Konda B, Sipos JA, Nabhan F, et al
    Prospects for Re-differentiating Agents in the Use of Radioactive Iodine Therapy for Thyroid Cancer.
    Thyroid. 2020 Feb 27. doi: 10.1089/thy.2020.0143.
    >> Share

  386. PEREIRA MM, Williams VL, Hallanger-Johnson JE, Valderrabano P, et al
    Thyroid Cancer Incidence Trends in the United States: Association with Changes in Professional Guidelines' recommendations.
    Thyroid. 2020 Feb 26. doi: 10.1089/thy.2019.0415.
    >> Share

  387. NIES M, Cantineau AEP, Arts EGJM, van den Berg MH, et al
    Long-Term Effects of Radioiodine Treatment on Female Fertility in Survivors of Childhood Differentiated Thyroid Carcinoma.
    Thyroid. 2020 Feb 20. doi: 10.1089/thy.2019.0560.
    >> Share

  388. CHEN JY, Ji QH, Bai C, Zheng X, et al
    Surufatinib in Chinese patients with locally advanced or metastatic differentiated thyroid cancer and medullary thyroid cancer: A multicenter, open-label, Phase II trial.
    Thyroid. 2020 Feb 19. doi: 10.1089/thy.2019.0453.
    >> Share

  389. NIEDERLE MB, Scheuba C, Riss P, Selberherr A, et al
    Early diagnosis of medullary thyroid cancer: Are calcitonin stimulation tests still indicated in the era of highly sensitive calcitonin immunoassays?
    Thyroid. 2020 Feb 14. doi: 10.1089/thy.2019.0785.
    >> Share

  390. CESAREO R, Pacella CM, Pasqualini V, Campagna G, et al
    Laser Ablation versus Radiofrequency Ablation for benign non-functioning thyroid nodules: Six-month results of a randomised, parallel, open-label, trial (LARA trial).
    Thyroid. 2020 Feb 14. doi: 10.1089/thy.2019.0660.
    >> Share

  391. ZHAO Y, Yu T, Chen L, Xie D, et al
    A Germline <i>CHEK2</i> Mutation in a Family with Papillary Thyroid Cancer.
    Thyroid. 2020 Feb 11. doi: 10.1089/thy.2019.0774.
    >> Share

  392. PEREZ-SOTO RH, Velazquez-Fernandez D, Arellano-Gutierrez G, Chapa Ibarguengoitia M, et al
    Preoperative and postoperative risk stratification of thyroid papillary microcarcinoma. A comparative study between Kuma criteria and 2015 ATA guidelines risk stratification.
    Thyroid. 2020 Feb 7. doi: 10.1089/thy.2019.0698.
    >> Share

  393. REN Y, Kyriazidis N, Faquin WC, Soylu S, et al
    The presence of Hurthle cells does not increase the risk of malignancy in most Bethesda categories in thyroid fine-needle aspirates.
    Thyroid. 2020 Feb 4. doi: 10.1089/thy.2019.0190.
    >> Share

  394. THOMAS J, Haertling T
    AIBx, artificial intelligence model to risk stratify thyroid nodules.
    Thyroid. 2020 Feb 4. doi: 10.1089/thy.2019.0752.
    >> Share

    January 2020
  395. GUAN H, Toraldo G, Cerda SR, Godley FA, et al
    Utilities of RAS mutations in pre-operative fine needle biopsies for decision-making for thyroid nodule management: results from a single-center prospective cohort.
    Thyroid. 2020 Jan 29. doi: 10.1089/thy.2019.0116.
    >> Share

  396. SARACYN M, Lubas A, Bober B, Kowalski L, et al
    <b>Recombinant human thyrotropin worsens renal cortical perfusion and renal function in patients after total thyroidectomy due to differentiated thyroid cancer</b>.
    Thyroid. 2020 Jan 22. doi: 10.1089/thy.2019.0372.
    >> Share

  397. LI M, Brito JP, Vaccarella S
    Long term declines of thyroid cancer mortality: an international age-period-cohort analysis.
    Thyroid. 2020 Jan 22. doi: 10.1089/thy.2019.0684.
    >> Share

  398. LIU L, Zhang X, Tian T, Huang R, et al
    Prognostic value of pre-ablation stimulated thyroglobulin in children and adolescents with differentiated thyroid cancer.
    Thyroid. 2020 Jan 22. doi: 10.1089/thy.2019.0585.
    >> Share

  399. GONZALEZ-VELAZQUEZ CD, O'Malley QF, Yue LE, Urken ML, et al
    Letter to the editor: Treatment decisions in thyroid microcarcinomas: Identifying gaps in knowledge to empower our patients.
    Thyroid. 2020 Jan 22. doi: 10.1089/thy.2019.0451.
    >> Share

  400. PERSICHETTI A, Di Stasio E, Coccaro C, Graziano FM, et al
    Inter- and Intra-Observer Agreement in the Assessment of Thyroid Nodule Ultrasound Features and Classification systems: A Blinded Multicenter Study.
    Thyroid. 2020 Jan 17. doi: 10.1089/thy.2019.0360.
    >> Share

  401. LEE YK, Hwangbo Y, Lee S, Lee DE, et al
    Aspirin use is not associated with lower thyroid cancer risk: A nationwide nested case-control study.
    Thyroid. 2020 Jan 17. doi: 10.1089/thy.2019.0641.
    >> Share

  402. SANABRIA A
    Experience with active surveillance of thyroid microcarcinomalow-risk carcinoma in a developing country.
    Thyroid. 2020 Jan 17. doi: 10.1089/thy.2019.0522.
    >> Share

  403. JACK GA, Sternberg SB, Aronson MD, Mukamal KJ, et al
    <b>Non-Diagnostic Fine-Needle Aspiration Biopsy of Thyroid Nodules: Outcomes and Determinants</b>.
    Thyroid. 2020 Jan 17. doi: 10.1089/thy.2019.0140.
    >> Share

  404. PAPARODIS R, Karvounis E, Bantouna D, Chourpiliadis C, et al
    Incidentally discovered papillary thyroid microcarcinomas are more frequently found in patients with chronic lymphocytic thyroiditis than with multinodular goiter or Graves disease.
    Thyroid. 2020 Jan 17. doi: 10.1089/thy.2019.0347.
    >> Share

  405. MORENO I, Hirsch D, Duskin-Bitan H, Diker-Cohen T, et al
    Response to Therapy Assessment in Intermediate-Risk Thyroid Cancer Patients- Is rhTSH Stimulation Required?
    Thyroid. 2020 Jan 13. doi: 10.1089/thy.2019.0431.
    >> Share

  406. HE H, Li W, Comiskey DF Jr, Liyanarachchi S, et al
    A truncating germline mutation of TINF2 in individuals with thyroid cancer or melanoma results in longer telomeres.
    Thyroid. 2020 Jan 13. doi: 10.1089/thy.2019.0156.
    >> Share

  407. VAN VELSEN EFS, Visser WE, van den Berg S, Kam BLR, et al
    Longitudinal Analysis of the Effect of Radioiodine Therapy on Ovarian Reserve in Females with Differentiated Thyroid Cancer.
    Thyroid. 2020 Jan 13. doi: 10.1089/thy.2019.0504.
    >> Share

  408. OH JM, Baek SH, Gangadaran P, Hong CM, et al
    A novel tyrosine kinase inhibitor can augment radioactive iodine uptake through endogenous sodium/iodide symporter (NIS) expression in anaplastic thyroid cancer.
    Thyroid. 2020 Jan 13. doi: 10.1089/thy.2018.0626.
    >> Share

  409. ZAFEREO M, McIver B, Vargas S, Dominguez Ruiz-Tagle JM, et al
    A THYROID GENETIC CLASSIFIER CORRECTLY PREDICTS BENIGN NODULES WITH INDETERMINATE CYTOLOGY: TWO-INDEPENDENT MULTICENTER, PROSPECTIVE VALIDATION TRIALS.
    Thyroid. 2020 Jan 7. doi: 10.1089/thy.2019.0490.
    >> Share

  410. ZHANG M, Tufano RP, Russell J, Zhang Y, et al
    Ultrasound-guided radiofrequency ablation versus surgery for low risk papillary thyroid micro-carcinoma: results of over 5 years follow-up.
    Thyroid. 2020 Jan 7. doi: 10.1089/thy.2019.0147.
    >> Share

  411. SUGINO K, Nagahama M, Kitagawa W, Ohkuwa K, et al
    Risk stratification of pediatric patients with differentiated thyroid cancer: Is total thyroidectomy necessary for patients at any risk? .
    Thyroid. 2020 Jan 7. doi: 10.1089/thy.2019.0231.
    >> Share

  412. JASIM S, Baranski T, Teefey S, Middleton WD, et al
    Investigating the effect of thyroid nodule location on the risk of thyroid cancer.
    Thyroid. 2020 Jan 7. doi: 10.1089/thy.2019.0478.
    >> Share

  413. YOSHIDA Y, Horiuchi K, Okamoto T
    Patients' view on the management of papillary thyroid microcarcinoma: active surveillance or surgery.
    Thyroid. 2020 Jan 7. doi: 10.1089/thy.2019.0420.
    >> Share

  414. JENSEN CB, Saucke MC, Francis DO, Voils CI, et al
    From Overdiagnosis to Overtreatment of Low-risk Thyroid Cancer: A Thematic Analysis of Attitudes and Beliefs of Endocrinologists, Surgeons, and Patients.
    Thyroid. 2020 Jan 7. doi: 10.1089/thy.2019.0587.
    >> Share

    December 2019
  415. YUAN Q, Wu G, Hou J, Liao X, et al
    Correlation between electrophysiological changes and outcomes of vocal cord function in 1764 recurrent laryngeal nerves with visual integrity during thyroidectomy.
    Thyroid. 2019 Dec 27. doi: 10.1089/thy.2019.0361.
    >> Share

  416. PARIHAR AS, Mittal BR, Kumar R, Shukla J, et al
    68Ga-DOTA-RGD2 PET/CT in radioiodine (131I) refractory thyroid cancer - Prospective comparison of diagnostic accuracy with 18F-FDG PET/CT and evaluation towards potential theranostics.
    Thyroid. 2019 Dec 23. doi: 10.1089/thy.2019.0450.
    >> Share

  417. JUN JK, Hwang SY, Hong S, Suh M, et al
    Association of screening by thyroid ultrasonography with mortality in thyroid cancer: a case-control study using data from two national surveys.
    Thyroid. 2019 Dec 23. doi: 10.1089/thy.2019.0460.
    >> Share

  418. MASAKI C, Sugino K, Saito N, Akaishi J, et al
    Efficacy and limitations of lenvatinib therapy for radioiodine-refractory differentiated thyroid cancer: real-world experiences.
    Thyroid. 2019 Dec 19. doi: 10.1089/thy.2019.0221.
    >> Share

  419. NERVO A, Ragni A, Gallo M, Ferraris A, et al
    SYMPTOMATIC BILIARY DISORDERS DURING LENVATINIB TREATMENT FOR THYROID CANCER: AN UNDERESTIMATED PROBLEM?
    Thyroid. 2019 Dec 19. doi: 10.1089/thy.2019.0355.
    >> Share

  420. CRAIG SJ, Bysice A, Nakoneshny SC, Pasieka JL, et al
    THE IDENTIFICATION OF INTRA-OPERATIVE RISK FACTORS CAN REDUCE, BUT NOT EXCLUDE, THE NEED FOR COMPLETION THYROIDECTOMY IN LOW-RISK PAPILLARY THYROID CANCER PATIENTS.
    Thyroid. 2019 Dec 6. doi: 10.1089/thy.2019.0274.
    >> Share

  421. CHOI Y, Jung SL
    Efficacy and safety of thermal ablation techniques for the treatment of primary papillary thyroid microcarcinoma: a systematic review and meta-analysis.
    Thyroid. 2019 Dec 4. doi: 10.1089/thy.2019.0707.
    >> Share

  422. PARK JL, Jeon S, Seo E, Bae DH, et al
    Comprehensive DNA methylation profiling identifies novel diagnostic biomarkers for thyroid cancer.
    Thyroid. 2019 Dec 4. doi: 10.1089/thy.2019.0011.
    >> Share

  423. VYDRO L, Kitahara CM, Lubin JH, Schneider AB, et al
    Among Individuals Irradiated for Benign Conditions in Childhood, Developing Thyroid Cancer Does Not Affect All-cause Survival.
    Thyroid. 2019 Dec 4. doi: 10.1089/thy.2019.0439.
    >> Share

    October 2019
  424. MASOODI T, Siraj AK, Siraj S, Azam S, et al
    Whole Exome Sequencing of Matched Primary and Metastatic Papillary Thyroid Cancer.
    Thyroid. 2019 Oct 31. doi: 10.1089/thy.2019.0052.
    >> Share

  425. FUZIWARA CS, Saito KC, Kimura ET
    Thyroid follicular cell loss of differentiation induced by miRNA miR-17-92 cluster is attenuated by CRISPR/Cas9n gene silencing in anaplastic thyroid cancer.
    Thyroid. 2019 Oct 3. doi: 10.1089/thy.2018.0601.
    >> Share

  426. JAIN NK, Mostoufi-Moab S, Hawkes CP, Nelson ND, et al
    Extrathyroidal Extension is an Important Predictor of Regional Lymph Node Metastasis in Pediatric Differentiated Thyroid Cancer.
    Thyroid. 2019 Oct 1. doi: 10.1089/thy.2019.0229.
    >> Share

    September 2019
  427. IANNI F, Pascucci D, Paragliola RM, Rota CA, et al
    Follow-up or surgery for indeterminate thyroid nodules: could the CUT score application be a support for decision making in the preoperative assessment?
    Thyroid. 2019 Sep 25. doi: 10.1089/thy.2018.0649.
    >> Share

  428. ZAHEDI A, Bondaz L, Rajaraman M, Leslie WD, et al
    Risk for Thyroid Cancer Recurrence Is Higher In Men Than In Women Independent of Disease Stage At Presentation.
    Thyroid. 2019 Sep 16. doi: 10.1089/thy.2018.0775.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016